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Chapter 1
Literature Review
Exopolysaccharides from lactic acid bacteria (LAB)
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Introduction
Exopolysaccharides (EPSs) are long-chain polysaccharides consisting of branched, repeating
units of sugars or sugar derivatives. These sugar units are mainly glucose, galactose and
rhamnose, in different ratios (De Vuyst & Degeest, 1999; Welman & Maddox, 2003).
Microorganisms synthesize a number of multifunctional polysaccharides including
intracellular polysaccharides, structural polysaccharides and extracellular polysaccharides or
exopolysaccharides (EPS). These are composed of monosaccharides and some non
carbohydrate substituents (such as acetate, pyruvate, succinate, and phosphate). Due to their
wide diversity in composition, they have been used in various food and pharmaceutical
industries (Suresh & Mody, 2009). This term was used for the first time by Sutherland in
1972, in order to describe carbohydrate polymers produced by marine bacteria with high
molecular weight. In their natural environment, most bacteria occur in microbial aggregates
whose structural and functional integrity is based on the presence of a matrix of extracellular
polymeric substances and the EPS production seems to be essential for their survival (Nichols
et ai, 2005; Poli et ai, 2010).
It has been reported that the ability to produce exopolysaccharides is widespread among
many microorganisms (Bubb et ai, 1997; Phyo et al., 2008). Several lactic acid bacteria
(LAB) are known to produce EPS (van Hijum et al, 2006), most of which belong to the
genera Streptococcus, Lactobacillus, Lactococcus, Leuconostoc, and Pediococcus. Previous
studies have also shown that certain strains of Bifidobacterium are also able to produce these
biopolymers (Ruas-Madiedo et al., 2005; Abbad-Andaloussi et al., 1995; Roberts et al,
1995; Hosono et al, 1997). Microorganisms can synthesize storage polysaccharides such as
glycogen which are positioned in the cytoplasm, in the case of Gram-positive bacteria the cell
wall structural polysaccharides such as peptidoglycan and lipoteichoic acids and the
lipopolysaccharides anchored in the outer membrane of Gram-negative bacteria (Phyo et al.,
2008). Moreover, some bacteria can secrete polysaccharide layers on their surface during
growth, which form a slime layer loosely attached to the cell surface or secreted into the
environment (Phyo et ai, 2008). This distinguishes them from the structurally similar
capsular polysaccharides (CPSs), which remain permanently attached to the surface of the
cell (Welman & Maddox, 2003).
The microorganisms that produce these bacterial EPSs do not use them as an energy source;
they functionally protect the bacteria from the natural environment by forming a capsule

(Looijesteijn et al., 2001; Whitfield & Valvano, 1993). They also play a key role in cell
recognition, in adhesion to surfaces and in formation of biofilms (Looijesteijn et al., 2001;
Whitfield & Valvano, 1993). It protects the microbial cell against dessication, phagocytosis
and phage attack, antibiotics or toxic compounds (e.g. toxic metal ions, sulfur dioxide,
ethanol), predation by protozoans, osmotic stress, adhesion to solid surfaces and biofilm
formation, and also in cellular recognition (e.g. via binding to a lectin) (De Vuyst et al, 1999;
Cerning, 1990).

Gram-positive

Gram-negative

Figure 1. Cell location of polysaccharides produced by Gram-positive and Gram
negative bacteria. CPS = Capsular polysaccharides (capsule), EPS =
exopolysaccharide (slime layer) (Ruas-Madiedo et al, 2005).

Exopolysaccharides associated with different bacteria
A great variety of microorganisms synthesize EPS. These EPS can then either remain
attached to the cell surface or form an amorphous slime in the extracellular medium
(Sutherland, 1998). Several LAB are known to produce EPS (van Hijum et al, 2006). As a
result of the potential benefits that LAB have on the quality of fermented dairy food products.
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a number of thermophilic and mesophilic LAB, and the polymers they produce, have been
analyzed (Pigeon et al., 2002). Streptococcus thermophilus (Doco et al., 1990; Cerning et al,
1992), Lactobacillus delhrueckii ssp. bulgaricus (Bouzar et al., 1992; Grobben et al., 1995),
other lactobacilli (Dunican & Seeley, 1965; De Vuyst & Degeest, 1999) and Bifidobacterium
longum (Abbad Andaloussi et al, 1995).
Acetobacter
Acetobacter is a Gram-negative, aerobic, rod-shaped bacterium. Its subspecies, Acetobacter
xylinum, has long served as a model organism for the study of bacterial cellulose (p (1-4)
linked D-glucose units) synthesis, mainly due to its ability to produce large quantities of this
polysaccharide (Ross et al, 1991). Bacterial cellulose has specific applications and usage; it
is essentially a high-value speciality chemical (Sutherland et al, 1998). Some are produced
commercially, for example ‘BioFilf, which is manufactured in the form of wound dressings
for patients with burns, chronic skin ulcers or other examples of extensive losses of tissue.
The cellulose works on the principle that it acts as a temporary' skin substitute. This oxygenpermeable film has a high water capacity which appears to stimulate the regrowth of skin
tissue, while at the same time limiting the possibility of infection (Sutherland et al., 1998).
A cineotohacier
Acineotobacter is a Gram-negative, strictly aerobic rod-shaped bacterium. The polymer
emulsan (which consists of D-galactosamine, D-galactosaminouronic acid, and a
dideoxydiaminohexose in the ratio 1:1:1) is secreted from Acinetobacter calcoaceticus.
Emulsan has its industrial applications as an emulsifier (Panilaitis et al., 2002).
Alcaligenes
Alcaligenes is a Gram-negative, rod-shaped, obligate aerobic bacterium. The species
Alcaligenes faecalis produces curdlan (beta-1, 3-glucan) under limiting nitrogen conditions. It
is used in the food industry possessing both heat-gelling and water-binding properties (Wu et
al., 2008). Levan (fructose polymer 2, 6 linkages) is produced in a number of components,
plants, yeasts, fungi and bacteria (Jang et al., 2002) including the

spQCiQS

Alcaligenes

viscosus. Derivatives of levan such as sulphated, phosphated or acetylated levans are asserted
to be anti-AIDS agents. In addition, it has a number of other applications, such as a coating
material in a drug delivery formulation, and in industry it acts as a surfactant for household
use (Kang et al, 2009).

A ureohasidium
The genus Aureobasidium is a black-yeast like fungus (Yurlova et al, 1996). It is commonly
isolated from plant debris, soil, wood, textiles, and indoor air environments. Pullulan (a-1, 4; a-1, 6-glucan) is produced from starch by the fungus Aureobasidium pullulans. It has a
number of uses including, acting as low-viscosity filler in beverages and sauces and in food
pastes act as a denture adhesive, a binder and stabilizer and is also used to adhere nuts to
cookies (Leathers, 2003).
Azotohacter
Azotobacter is an aerobic. Gram-negative bacterium, oval or spherical in shape. It has a
number of applications. The species Azotobacter vinelandii produces the exopolysaccharide
alginate (1-4-linked p-D-mannuronate) (Clementi, 1997). Bacterial alginates have specific
usage; they are essentially used for the production of micro-or nanostructures suitable for
medical applications (Remminghorst & Rehm, 2009). The sptciQS Acetobacter xylinum
produces the exopolysaccharide acetan (glucose, mannose and glucuronic acid and rhamnose
in the proportions of 4; 1:1:1) (Ishida et al., 2002). This is used in industry as a viscosifier and
gelling agent (van Kranenburg et al, 1999).
Bifidohaclerium
Bifidobacterium are Gram-positive, rod-shaped, anaerobic bacteria and certain strains of this
genus are also able to produce these biopolymers. A number of studies have been carried out
on the EPS produced by Bifidobacterium longum and they have shown that this EPS has
specific functions, such as adhesion to the inner surfaces of the intestine (Abbad Andaloussi
et al, 1995), promotion of colonization (Roberts et al., 1995) and strong anti mutagenesis
effects (Sreekumar & Hosono, 1998; Kohno et al., 2009).
Lactobacillus
In the last decade, synthesis of EPS by LAB has been studied extensively (De Vuyst &
Degeest, 1999; De Vuyst et al, 2001; Welman & Maddox, 2003; Van der Meulen et al.,
2007). This is due to the large variety of EPS produced by an equally large number of LAB
(Cerning, 1990; van den Berg et al., 1995). The majority of these strains were isolated from
dairy products, however, another source of these EPS-producing LAB strains were from
fermented meats (Makela et al., 1992; van den Berg et al, 1995). The Generally Recognized
as Safe (GRAS) status of LAB allows the in situ production of EPS in different food products
(e. g. yoghurt and cheese), which meets the consumer's demand for products with low levels
9

of additives (De Vuyst et ai, 2001; Jolly et al, 2002; Van der Meulen et ai, 2007).
Looijesteijn and co-workers (2001) recently published works which showed that the EPS
produced by Lactococcus lactis subsp. cremoris NZ4010 acted in protecting the bacteria
against several anti-microbial factors such as bacteriophages, metal ions, nisin and lysozyme
(Ruas-Madiedo et al, 2002). Lactobacillus kefiranofaciens is associated with the kifir grains
producing the kefiran polymer (contains approximately equal amounts of glucose and
galactose) which is responsible for the matrix of the kefir grain (Kooiman, 1968; Toba et ai,
1987; Mukai et al, 1990; Yokoi et al, 1990; De Vuyst & Degeest, 1999). This polymer has a
number of uses not only in the food industry as a thickener, stabilizer, emulsifier, fat
substitute or gelling agent, but also this polymer shows antitumor activity (Shiomi et al,
1982; Cheirsilp et al, 2003). EPS strains of S. therniophilus and Lactobacillus delbrueckii
subsp. bulgaricus are commonly used as a substitute for commercial stabilizers in yogurt
manufacture due to their ability to reduce syneresis and enhance product texture and viscosity
(Cerning, 1995). Although use of EPS LAB starters is far less common in cheese
manufacture, recent work has shown that EPS S. therniophilus can improve the functional
properties of low fat or part-skim mozzarella cheese (Perry et al, 1997; Low et al, 1998;
Petersen et al, 2000; Broadbent et al, 2003).
Lentinus
This bacterium is a genus of fungi from the family Polyporaceae. Lentinus elodes a common
edible mushroom produces the polymer lentinan (beta-glucan with a glycosidic p-l, 3: P-1, 6
linkage) (Zhange et al, 2001). Research has shown that this derivative has both antitimor/anti-viral activities when administered orally and by injection, both in animal and in
hnmans. It was found that lentinan works on the basis of enhancing various immune system
functions rather than attacking the tumor cells or viruses themselves (Kwon & Hobbs, 2005).
Leuconostoc
The bacterium Leuconostoc closely resembles the genus Lactobacillus in that it is Grampnsitive, rod-shaped, and facultative anaerobic (Bjorkroth & Holzapfel, 2006). In 1878, the
EPS-producer Leuconostoc mesenteroides was discovered and shown to be responsible for
tte thickening and gelling of sugar beet and sugar cane syrup. It is seen as the start of
possible uses of EPS synthesized from LAB in food product (De Vuyst & Degeest, 1999).
Cextran (glucan with a-1, 6: a-1, 3 linkages) is produced as an exopolysaccharide by
Leuconostoc mesenteroides. This polymer has a number of uses including the following; use
for the production of chromatography supports for gel permeation separation (Sephadex) in
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the production of blood plasma substitutes (Monsan et al., 2001) and also used to prepare
dextran sulphate for blood coagulation prevention and iron transport (Soetaert et al, 1995).
Nostoc commune (Cyanobacteria)
Many microorganisms including cyanobacteria {Nostoc commune) include unicellular and
colonial species. They synthesis exocellular polysaccharides and it has been hypothesised that
these play a major role in protecting cells from stress in extreme habitats and from other
harmful conditions. Some polysaccharide-producing cyanobacteria have the ability to
overcome stress due to desiccation or to low water activity in desert or saline environments
(De Philippis et al, 1998). Hill et al, (1994) proposed that a desiccation-tolerant
commune strain is due to the secreted glycan which provides a repository for water, thereby
acting as a buffer between cells and the atmosphere and representing the key component of
the mechanism used by this cyanobacterium to tolerate desiccation.
Rhodococcus
Rhodococcus is a genus of aerobic, rod-shaped. Gram-positive bacteria. Two major factors
have stimulated an interest in EPS of Gram-positive Rhodococcus species. The first of these
factors is their role in pathogenicity. Woolcock & Mutimer (1978) showed that the
pathogenic Rhodococcus equil synthesize EPS that plays a major role in the virulence of this
zoonic pathogen, this then causes equine necrotizing pneumonia. The second of these factors
is this EPS was demonstrated to play a role in the bacterial degradation of non-polar aromatic
and aliphatic compounds (Perry et al, 2007).
Schizophyllum
This bacterium is a genus of fungi in the family Schizophyllaceae. Schizophyllan (1, 3-P-Dlinked backbone of glucose residues with 1, 6-p-D-glucosyl side groups) is produced by the
fungi Schizophyllum commune. It has a number of properties including the ability to stimulate
the human immune system. It acts as a colloidal carrier for trace metals and pollutants in
natural water, it is also used in industry as a viscosity-control agent and it plays a role in the
formulation of matrices for drug delivery (Kony et al, 2007).
Sclerotium
Sclerotium is a genus of fungi from the family Typhulaceae. Hal leek (1965) was the first to
report that Sclerotium glucanicum secreted the polymer scleroglucan (P-D-(l-3)glucopyranosyl units; there is a p-D-glucopyranosyl unit (1-6) linked to every third unit).
Initially this polymer was used in the oil recovery industry as it showed superior efficiency

and stability over a wide range of pH and temperature in comparison to the polymer xantan.
It increases the viscosity and hence the hydraulic pressure of the water used to extract the oil.
Today however this polymer is not seen as being as economical as xantan. It is used in the
medical market due to its properties in controlled drug release and especially in
immunopharmaceutical applications (Survase et ai, 2007).
Sphingomonas
Sphingomonas is a group of Gram-negative, rod-shaped, strictly aerobic bacteria. Yabuuchi et
ai, (1990) proposed the genus Sphingomonas to describe a group of bacterial strains isolated
from human clinical specimens and hospital environments. Since, this genus has also been
isolated from a variety of anthropogeneously contaminated environments (Leys et ai, 2004).
Gellan (linear repeating tetrasaccharides unit composed of glucose, rhamose and glucuronic
acid) is synthesised from Sphingomonas paucimobilis. Gellan has a number of uses and is
employed in the plant biotechnology sector as a gelling agent under the trade name of gelrite
or phytogel (Sutherland, 2002).
Streptococcus
Many strains of Streptococcus thermophilus synthesize extracellular polysaccharides. The
EPS produced from these strains may be in the form of capsules which are tightly associated
with the cell, or they may be liberated into the medium as a loose slime (i.e. “ropy”
polysaccharide) (Broadbent, 2003). The EPS synthesized from S. thermophilus strains are
heteropolysaccharides that show a large diversity with respect to their monomer composition,
molecular weight (MW) and structure of the repeating unit (Shene et al, 2008). Doco et al,
(1990) found the first S. thermophilus EPS structure to be determined was that of the EPS
from the strains CNCMl 733, 734, and 735. There are no obvious advantages that the
presence of exopolysaccharide confers on the growth or survival of S. thermophilus in milk,
in situ production by this species or other dairy LAB typically imparts a desirable “ropy” or
viscous texture to fermented milk products. Recent studies have also shown that
exopolysaccharide producing S. thermophilus can magnify the functional properties of
mozzarella cheese, but they are not phage-proof (Broadbent, 2003). The EPSs produced by
Streptococcus salivarius and S. mutans are involved in the bacterial colonization and
formation of dental plaque (Cerning, 1990; Ruas-Madiedo et al, 2002).
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Xanthomonas
I'he gQnus Xanthomonas is a Gram-negative, rod-shaped bacterium containing a large
number of strains (da Silva et al, 2002). Xanthomonas campestris produces the polymer
xanthan (Sutherland, 2002) (a polysaccharide with a p-D-glucose backbone like cellulose, but
every second glucose unit is attached to a trisaccharide consisting of mannose, glucuronic
acid and mannos). It was the very first microbial polysaccharide that was allowed in food
products (De Vuyst & Degeest, 1999). This is used in the food industry as a suspending and
stabilizing agent for oil/water emulsions such as salad dressings. It is also used widely in the
oil exploration and development sector for lubricating drills. It provides an excellent
suspending agent for removing the rock cuttings released on drilling; it is also compatible
with barites, used to counteract the high pressures of reservoirs (Sutherland. 2002).

Figure 2. General layout of the classification of bacterial EPSs
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Diversity of exopolysaccharides in lactic acid bacteria
Classification of exopolysaccharides from lactic acid bacteria
Depending on their chemical composition and mechanism of biosynthesis, EPS can be
divided into two categories; heteropolysaccharides and homopolysaccharides (De Vuyst &
Degeest, 1999; van Hijum et ai, 2006). Heteropolysaccharides (HePS) are comprised of
repeating units of different monosaccharides and are synthesized by the combined action of
multiple different types of glycosyltransferase enzymes (De Vuyst & Degeest, 1999; van
Hijum et ai, 2006). These repeating subunits are cither branched (at positions C2, C3, C4, or
C6) or unbranched, and consist of three to eight monosaccharides, derivatives of
monosaccharides or substituted monosaccharides. The monosaccharides are present as a-or panomer in the pyranose or furanose form (De Vuyst et ai, 2001). Heteropolysaccharides are
produced by mesophilic {Lactococcus lactis subsp. Iact is, L. lactis subsp. cremoris,
Lactobacillus casei, Lh. sake. Lb. rhanmosus, etc.) and thermophilic {Lb. acidophilus. Lb.
delbrueckii subsp. bulgaricus. Lb. helveticus and S. thermophilus) LAB strains (De Vuyst &
Degeest, 1999).
Homopolysaccharides (HoPS) contains a single type monosaccharide, fructose or glucose,
respectively, the fructans and the glucans (van Hijum et ai, 2006; Monsan et ai, 2001).
Many of these homopolysaccharides have the ability of being synthesized by extracellular
glycansucrases using sucrose as the glycosyl (fructose or glucose) donor. Unlike the majority
of polysaccharides, these polymers are not generally produced by glycosyltransferases which
use nucleotide-sugar precursors, but by transglycosylases (glycansucrases), which are able to
use the energy of the osidic bond of sucrose to catalyse the transfer of a corresponding
glycosyl moiety (Monsan et ai, 2001).

Glucansucrase

Glucan + Fructose

Fructansucrase

Fructan + Glucose

Sucrose

Figure 3. The production of these polymers by glucansucrases or fructansucrases
which are able to use the energy of the osidic bond of sucrose to catalyse the transfer
of a corresponding glycosyl moiety namely Glucan + Fructose or Fructan + Glucose
(Monsan et al, 2001).
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Based on their structures, homopolysaccharides can be distinguished into four subgroups: (a)
a-D-glucans, i.e. dextrans, mutan and alternan, (b) |3-D-glucans, (c) fructans, such as levan
and (d) others, like polygalactan (Table 1.) (De Vuyst & Degeest, 1999; Ruas-Madiedo et al,
2002). These are composed of structurally identical repeating units with variable degrees of
branching and different glycosidic linkages, which is different among bacterial strains (De
Vuyst & Degeest, 1999; Ruas-Madiedo et al, 2002; Monsan et al, 2001).
a-D-glucans
Glucansucrases catalyse the synthesis of a variety of glucans containing mostly a-1,6, a-1, 3,
a-1,4 and a-1, 2 linked d-glycosyl units (Sidebotham, 1974; Monchois et al., 1999).

H

OM

Figure 3. Structures of glucans (A) dextran, containing mostly a-1, 6 osidic bonds,
(B) mutan, containing mostly a-1, 3 glucosidic linkages and, (C) alternan, containing
alternating a-1, 6 and a-1, 3 glucosidic linkages (Monsan et al, 2001).
15

Fructan
Levan and inulin both of which contain |3-2, 6 and p-2, 1 osidic bonds, respectively, are the 2
types of fructose homopolysaccharides produced by fructosyltransferases from sucrose
(Monsan et ai, 2001).

A

B

Figure 4. Structures of glucans (A) levan, levansucrase catalyses the transfer of Dfructosyl residues from fructose to yield the P-2, 6 osidic bond, (B) inulin-type
fructan, containing p-2, 1 osidic bond (Monsan et al, 2001).
The following are necessary to determine the physical characteristics, and hence their
viscosity-intensifying properties; chemical composition, chain length, and structure of these
subunits, together with the molar mass and radius of gyration of the EPS molecule (Laws et
jL,

2001; Tuinier et al., 2001; Ruas-Madiedo et ai, 2005). The HePS range in size from

•1x10"^ to 6x10^ Da, and HoPS can be even larger (Phyo et al, 2008; Ceming, 1990). One of
he factors that determine the functional properties of EPS is their molecular mass (Cerning et
iL, 1992; van den Berg et al, 1995; De Vuyst & Degeest, 1999). The amount of EPS
produced by LAB can be influenced by a number of factors, namely composition of the
16

medium and growth conditions; it has also been found that HoPS are generally produced in
larger quantities than HePS (Phyo et al., 2008).
Table 1. Homopolysaccharides produced by some LAB
EPS
a-D-glucans

Strain

Linkage^

Dextran

Leuconostoc mesenteroides subsp.
mesenteroides
Leuconostoc mesenteroides subsp. Dextranicum
Streptococcus mutans
Streptococcus sobrinus
Leuconostoc mesenteroides

a-D-Glc/(l-6)

Pediococcus spp.
Streptococcus spp.

P- D-G1c/7(1-3)

Mutan
Alteman
P-D-glucans

a-D-Glcp'’(l-3)
a-D-Glc/7(l-3)/(l-6)

Fructans
Levans
Streptococcus salivarius
Inulin-like
Streptococcus mutans
Polygalactan L. lactis subsp. lactis H414

P- D- Fru;? (2-6)
P- D- Frup(2-1)
a-D-Gal/?/ (3- DGalp"

^Glc: glucose; Gal: galactose; Fru: fructose.
'’At least 50% of the respective linkage.
Homopolysaccharide containing a pentameric repeating unit of galactose.
Chemical composition of exopolysaccharides from lactic acid bacteria
The chemical composition of EPS from LAB has long been controversial. Both Sundman
(1953) and Nilsson and Nilsson (1958) first studied the nature of this “slime material” from
LAB and found it to be a protein-like material (De Vuyst & Degeest, 1999). There is now
agreement and has been cited by Ceming (1995) that the exopolymers from LAB are
polysaccharides composed of (branched) repeating units, containing a- and p-linkages, and
that many different types are secreted. However, their monomer composition seems to be
remarkably similar.

Biosynthetic pathways leading to EPS synthesis in LAB
Glucose-6-phosphate is the key intermediate which appears to link the anabolic pathways of
EPS production and the catabolic pathways of sugar degradation, in which the flux of carbon
bifurcates between the formation of fructose-6-phosphate toward the products of glycolysis,
17

biomass and ATP formation and toward the biosynthesis of sugar nucleotides, the precursors
of EPSs (Figure 5) (Welman & Maddox, 2003). The conversion of glucose-6-phosphate to
glucose-1-phosphate, involves the enzymes phosphoglutcomutase (PGM), which may also
potentially play an important role in the divergence of flux between these catabolic and
anabolic pathways (Hugenholtz et al, 1999; Degeest & de Vuyst, 2000). The conversion of
glucose-6-phosphate to glucose-1-phosphate involves the enzymes phosphoglutcomutase
(PGM), which may also potentially play an important role in the divergence of flux between
these catabolic and anabolic pathways (Hugenholtz et al, 1999; & de Vuyst, 2000). Glucose1-phosphate serves as a branch point for the formation of the sugar nucleotides UDP-glucose
and dTDP-glucose via the action of UDP-glucose pyrophosphorylase and dTDP-glucose
pyrophosphorylase, respectively. Note that these sugar nucleotides are used to form a variety
of polysaccharides in the cell and hence the enzymes associated with their formation are
shared (often termed ‘housekeeping enzymes’). Conversion of galactose to glucose-1phosphate via galactose-1-phosphate (the Leloir pathway) is possible if the system is present
in the cell (Welman & Maddox, 2003).
The next stage of EPS synthesis in LAB involves the assembly of the monosaccharide
repeating unit, which is achieved by several EPS-specitlc enzymes, as identified initially in
Streptococcus thermophilus Sfi6 (Stingcle et al., 1996) and in L lactis NIZO B40 (Van
Kranenburg et al, 1997). This repeating unit is assembled on a C55-isoprenoid-lipid carrier
molecule, which is attached to the cytoplasmic membrane of the cell (Van Kranenburg et al,
1999).
The sugars are joined to form the repeating unit by the action of several gene products on the
EPS gene cluster (glycosyltransferases) (Boels et al, 2001). The mechanism of
polymerization of the repeating unit in LAB, and its subsequent export from the cell, is
unclear. The high level of homology between Gram-positive and Gram-negative organisms
with respect to the repeating unit synthesis means that it is possible that a similar mechanism
will occur at the level of EPS polymerization and export (Welman & Maddox, 2003).
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Figure 5. Generalized diagram of the conversion of lactose, galactose and glucose to
EPS, In lactose-utilizing galactose-negative strains (e.g. Lactobacillus delbnieckii
subsp. bulgaricus) galactose is not metabolized and is expelled from the cell via a
lactose/galactose antiport system (Welman & Maddox, 2003).

Conditions for optimal EPS production by lactic acid bacteria
Biosynthesis and secretion of EPS from LAB occurs during different growth phases and the
growth conditions influences both the amount and type of polymer produced (De Vuyst &
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Degeest, 1999). The total yield of EPS produced by LAB is influenced by a number of
factors, namely composition of the medium (carbon and nitrogen sources) and the growth
conditions to which the strains are subjected (temperature, pH, incubation time) (De Vuyst &
Degeest, 1999; Phyo et ai, 2008). Sutherland (1994) cited that there was an increase in EPS
production resulting from nitrogen limitations in some EPS-producing bacteria e.g.
Xanthomonas, Pseudomonas and Rhizobium spp. However, it was found that, in the case of
LAB, in order to achieve high EPS yields, an optimal balance between carbon and nitrogen
was necessary (De Vuyst et al, 1998). This raises the possibilities that other medium
components such as minerals, some amino acids, and/or some bases and vitamins, may also
have an effect on the composition of the EPS produced (De Vuyst & Degeest, 1999).
Research by Gamer et al (1997) and Mozzi et ai, (1995) found that EPS production was
affected by mineral requirements and Grobben et ai, (1998) found that the presence of
vitamins played an important role in EPS production. Studies have indicated that the carbon
source, which is added to the screening media, plays a role in the detection of the EPS
phenotype in LAB; the total amount of polysaccharide produced seems to be strongly
influenced by the sugar available in the medium. However no unique sugar gives the best
results. In each case, the most suitable carbon source used is largely dependent on the strain
tested (Ruas-Madiedo et ai, 2005). Work completed by Cerning (1994) showed that
Lactobacillus casei CGI 1 synthesises EPS in basal medium containing glucose at a higher
rate than in basal medium containing lactose or galactose. However, later studies by Mozzi et
al (2001) found that Lactobacillus casei CRL87 synthesised EPS 1.7-fold higher in galactose
than in glucose.
Several studies showed that, for improved EPS yields, optimal conditions of temperature and
pH are all necessary (Gamar et ai, 1997; De Vuyst et ai, 1998; Gancel et ai, 1994; Mozzi et
ai, 1995; Gassem et ai, 1997; Gancel et ai, 1994; Mozzi et ai, 1995, 1996). Many LAB
produce their EPS optimally in temperature other than their optimum. Streptococcus
thermophilus and Lactobacillus bulgaricus have been shown to have an increase EPS
production when incubated at 32 or 37 °C rather than at temperatures as high as 42 °C (Mozzi
et ai, 1995; Cerning, 1995). Similarly mesophilic LAB have demonstrated a 50% higher EPS
production when incubated at 25 °C instead of 30 °C (Cerning et ai, 1992). Gassem et ai,
(1997) suggested that an increase in EPS production results from maintaining the pH at a
high pH and in turn increasing the time the culture remains in the exponential growth phase.
Higher pH also results in a longer stationary phase, which would decrease peptidoglycan and
20

teichoic acid syntheses and could result in increased EPS production. In addition to the above
conditions it is also worth mentioning that culture aeration is not necessary as higher EPS
yields could be obtained with a lower oxygen tension (De Vuyst et al, 1998; De Vuyst &
Degeest, 1999), as well as anaerobically (De Vuyst et al, 1998).

Applications of EPS
EPS have played a number of roles both in natural and man-made environments, one which is
a structural role in 'biofilms’, which is the normal home for many microbial communities
varying in numbers of prokaryotic and eukaryotic microorganisms, which grow here while
attached to solid-liquid interfaces (Sutherland, 1998). Several natural microbial
polysaccharides are now widely accepted products of biotechnology, while others are in
various stages of development. These polymers have many uses, which vary widely-some are
employed because of their unique or superior physical properties relative to traditional plant
polysaccharides (Sutherland, 1998).
Purified EPS as food ingredients
EPS produced by LAB and other bacteria are used in the food industry as viscosifiers,
stabilizers, emulsifiers, or gelling agents to modify the rheological properties and texture of
products and finally as physical stabilizers, where they can bind water and limit syneresis
(Duboc & Mollet, 2001; Phyo et al, 2008; Ruas-Madiedo et al, 2005). Examples of some
are xanthan, acetan, and gellan; produced by the Gram-negative

hdiCiQvxdi

Xanthomonas

campestris, Acetobacter xylinum, and Sphingomonas paucimovilis, respectively, or dextran
produced by strains of the LAB Leuconostoc mesenteroides (van Kranenburg et al, 1999).
These bacterial EPS are used as food additives, as food syrup stabilizers and dough
improvers. The polysaccharide levan may be used as a biothickener in foods, while the
polysaccharide alternan has potential eommercial applications as low viscosity bulking agent,
extender, etc. in foods and cosmetics. This is due to their unique structure of alternating a-1,
6- and a-1, 3-Iinkages, which is thought to be responsible for its distinctive physical
properties of high solubility and low viscosity (De Vuyst & Degeest, 1999; De Vuyst et al,
2001).
In situ production of EPS in fermented foods
One important mode of applying these sugars is by the deliberate addition of an EPS
producer to a food system. The best example is the addition of EPS-producing LAB to
21
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fermented food systems. Lactic acid bacteria, dairy propionibacteria, and bifidobacteria are
generally recognised as safe (GRAS) food grade microorganisms. Accordingly, these
microorganisms can produce large quantities of EPS (Cerning, 1990, 1995; AbbadAndaloussi et al, 1995; De Vuyst & Degeest, 1999; Roberts et ai, 1995; Ricciardi &
dementi, 2000; De Vuyst et ai, 2001). Moreover, when these microorganisms are used for
the in situ production of EPS, particularly for fermented dairy products, they frequently bring
about improvements in rheological properties, texture, body and mouthfeel (De Vuyst et al,
2001) . LAB starter cultures may also produce these EPS in situ during milk fermentation
(e.g. yogurt and Scandinavian fermented milk "viili"). Scandinavian ropy fermented milk
drinks like viili display a firm, thick, slimy consistency (Toba et al, 1990; De Vuyst &
Degeest, 1999; De Vuyst et al, 2001). The LAB isolated from this product is known to
produce EPS (Laws et al, 2001). They rely upon the souring capacity of mesophilic ropy
strains of L lactis subsp. lactis and L. lactis subsp. cremoris and the concomitant production
of HePS for texture. In other parts of Europe and the United States, dairy starter cultures that
produce slime-forming LAB strains are commercially available. Some countries throughout
the EU use ropy, thermophilic LAB starter cultures for yoghurt production. The reason for
this being that the addition of stabilizers is prohibited in yoghurts. The problem with this is,
thermophilic LAB produces less HePS therefore resulting in an unstable ropy character. For
this reason, in recent years, much attention has been on the use of EPS-producing strains as a
natural source of food biothickeners (Duboc & Mollet, 2001, Phyo et al., 2008; RuasMadiedo et al., 2005). Not only do EPS from LAB have ecological functions, they also have
technological significance in the production of several fermented dairy products. For the
production process of yoghurts a common practice of “ropy” starters containing EPS-forming
S. thermophilus and Lactobacillus delhrueckii subsp. hulgaricus are used in order to improve
texture, avoiding syneresis and increase the viscosity of the yoghurt (Ruas-Madiedo et al,
2002) . In food preparations, many LAB are used routinely due to their preservative effects:
the acidification, resulting from sugar metabolism, restricts further microbial contamination
(Laws et al, 2001).
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Table 2. Examples of applications of microbial exopolysaccharides
Polymer
Bacterial cellulose
(P (1-4) linked D-glucose
units)
Acetan (glucose, mannose
and glucuronic acid and
rhamnose in the
proportions of 4:1:1:1)
Emulsan (consists of Dgalactosamine, Dgalactosaminouronic acid,
and a
dideoxydiaminohexose in
the ratio 1:1:1)
Curdlan (beta-1, 3-glucan)
Levan (fructose polymer
2, 6 linkages)

Pullulan (a-1, 4-;a-l, 6glucan)
Alginate (P (l-4)-linked PD-mannuronate)
Kefiran polymer (contains
approximately equal
amounts of glucose and
galactose)

Lentinan (beta-glucan
with a glycosidic P-1,3:
P-1,6 linkage)
Dextran (glucan with a-1,
6: a-1, 3 linkages)

Application
Wound dressings

Bacterium
Acetohacter
xylinum

References
Sutherland et al,
1998

Viscosifier and gelling
agent

Acetohacter
xylinum

van Kranenburg
et al., 1999

Emulsifier

Acinetobacter
calcoaceticus

Panilaitis et al,
2002

Alcaligenes
fae calls
Anti-AIDS agents,
Alcaligenes
coating material in a drug viscosus
delivery formulation, in
food as a biothickener
Food industry

Food coatings, lowviscosity fillers in
beverages
Medical applications

A ureobasidium
pullulans

Production of
chromatography
supports, blood
coagulation prevention
and iron transport, in the
paper and metal-plating
processing

Leuconostoc
mesenteroides

Wu etai, 2008
Kang et al., 2009;
De Vuyst &
Degeest, 1999;
De Vuyst et al.,
2001.
Leathers, 2003

Azotohacter
Remminghorst &
Rehm, 2009
vinelandii
Food industry as a
Lactobacillus
Kooiman, 1968;
thickener, stabilizer,
kejiranofaciens Toba et a/., 1987;
emulsifier, fat substitute
Mukai et al.,
or gelling agent but also
1990; Yokoi et
this polymer shows
al, 1990; De
antitumor activity
Vuyst & Degeest,
1999; Shiomi et
al, 1982;
Cheirsilp et al,
2003
Enhancing various
Kwon & Hobbs,
Lentinus
immune system functions elodes
2005
Monsan et al,
2001; Soetaert et
al, 1995; De
Vuyst & Degeest,
1999; De Vuyst et
al, 2001.
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Polymer

Application

Bacterium

References

Schizophyllan (1, 3-P-D1 inked backbone of
glucose residues with 1, 6p-D-glucosyl side groups)

Ability to stimulate the
human immune system,
colloidal carrier for trace
metals, in industry as
viscosity-control agent,
formulation of matrices
for drug delivery
Initially this polymer was
used in the oil recovery
industry, however today
this polymer is not seen
as being as economical
as xantan, it is used in the
medical market due to its
properties in controlled
drug release and
especially in
immunopharmaceutical
applications
Plant biotechnologygelling agent

Schizophyllum
commune

Kony et al, 2007

Sclerotium
glucanicum

Survase et al,
2007

Sphingomonas
paucimohilis

Sutherland, 2002

Food industry as a
suspending and
stabilizing agent, oil
exploration and
development sector for
lubricating the drill,
suspending agent for
removing the rock
cuttings

Xanthomonas
campestris

Sutherland, 2002

Scleroglucan (p-D-(l-3)glucopyranosyl units;
there is a p-Dglucopyranosyl unit (1-6)
linked to every third unit)

Gellan (linear repeating
tetrasaccharides unit
composed of glucose,
rhamose and glucuronic
acid)
Xarthan (is a
polysaccharide with a PD-glucose backbone like
cellulose, but every
second glucose unit is
attached to a trisaccharide
consisting of mannose,
glucuronic acid and
mannos)

EPS in non-food applications
Indjstrial manufacturers have not yet intentionally exploited the EPS synthesized from LAB
hov/ever, concerning HoPS producing LAB there are a few exceptions (Sutherland, 1986;
Ro ler & Dea, 1992; De Vuyst et al, 2001). There are several commercial uses for dextran
dervatives and activated dextrans. Industrial dextrans are used in the manufacture of gel
filt-ation products and as blood volume extenders and blood flow improvers. Other possible
use> of dextrans include the use in enhanced oil recovery, in paper and metal-plating
pro:esses (De Vuyst & Degeest, 1999; De Vuyst et al, 2001).

24

Negative attributes associated with EPS
Studies carried out by Chhour et al, (2005) found increasing evidence linking a number of
Lactobacillus species with advanced stages of dental caries (van Hijum et al., 2006).
Apparently it has been found that both glucans and fructans, both of which are formed from
oral streptococci (and lactobacilli), have major influences on the formation of dental plaque.
Both of these polymers are involved in the adherence of bacteria to one another and to the
tooth surface, modulating diffusion of substances through plaque, sometimes they serve as
extracellular reserves (Colby et al., 1995; Dewar & Walker, 1975; Parker & Creamer, 1971;
Russell, 1994; van Hijum et al., 2006).
Other negative attributes associated with EPS synthesis is in relation to their spoilage
properties (Laws et al., 2001). Research by Lonvaud-Funel (1999) showed that EPS
synthesised by LAB during wine and cider production leads to these products having
undesirable rheological properties (Laws et al., 2001). Biofilm formation is produced from
EPS synthesised from LAB (Poulsen, 1999) and can result in biofouling (Laws et al., 2001).
An example of biofouling can be seen with biofilm formation in the equipment used for the
processing of dairy products. Biofilms cause a significant number of technical and hygiene
problems for the dairy industry (Poulsen, 1999).

Health Promoting Activity of EPS from LAB
It has been suggested that the EPS produced by LAB could in fact exert a beneficial effect on
human health (Salazar et al., 2008). German et a/ (1999) hypothesized that one physiological
beneft is that these EPS will remain for a longer period of time in the gastrointestinal tract
and ir doing so will enhance the colonization by probiotic bacteria (Welman & Maddox,
2003). Many probiotic bacteria, namely lactobacilli and bifidobacteria, are known to produce
EPS. t has been suggested that the health promoting effect of these EPS-producing strains
are related to the biological activities of these polymers (Ruas-Madiedo et al., 2002).
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Figure 6. Schematic representation of the possible health-promoting properties of
exopolysaccharides produced by lactic acid bacteria (Ruas-Madiedo et al, 2002).
Prebiotic effects
Another beneficial effect is the possibility of these polymers acting as prebiotic substrates
(Salazar et al, 2008; Phyo et al, 2008). Ingestion of prebiotics is one way in which a positive
effect on the composition of the intestinal microflora and their metabolic activity can be
achieved (Bello et al., 2001). As previously stated, prebiotics are nondigestible food
ingredients that beneficially affects the host by selectively stimulating the growth and/or
activity of one or a limited number of bacteria in the colon that can improve the host health
(Gibson, 1999). The possibility of acting as prebiotic substrates has been demonstrated
successfully by research carried out by Korakli and co-workers (2002) for a fructan-type EPS
produced by one strain of Lactobacillus sanfranciscemis (Salazar et al, 2008).
Antitumoral activity
In addition to having prebiotic effects it has been claimed that EPS produced by some LAB
exhibit antitumor effects (Kitazawa et al; 1998; Phyo et al, 2008). It has also been suggested
by Kitazawa et al, (1991) that these polymers may have anticarcinogen activity. These
authors found that intraperitoneal injection of lyophilised L. lactis subsp. cremoris KVS 20
cells caused the inhibition of Sarcoma-180 tumors in mice. However in

vitro’’" studies

against S-180 tumor cells it became clear that the LAB strain did not exhibit cytotoxicity.
From these results, it is hypothesised that the effectiveness of L. lactis subsp. cremoris KVS
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20 in the prevention of tumor proliferation was mediated through immune activity. It was
postulated that the principal component in the anti-tumoral effect may in fact be from the
slime material produced by L. lactis subsp. cremoris KVS 20. Research carried out at a later
stage by Santos et ai, (2003) involved testing Lactobacillus spp. isolated from kefir for their
ability to adhere to human enterocyte-like Caco-2 cells, their resistance to acidic pH and bile
acid, their antimicrobial activities against enteropathogenic bacteria, and finally for the
inhibition of Salmonella typhimurium attachment to Caco-2 cells. They found that the species
L. kejiranofaciens CYC 10058 synthesized an exopolysaccharide, which was closely related
to kefiran, a polysaccharide with antitumoral properties. Recent research carried out by Kim
et ai, (2010) investigated the antitumour effects of cell-bound exopolysaccharides (cb-EPS)
isolated from the species Lactobacillus acidophilus 606 on colon cancer cells. They found
that cb-EPS were antitumourigenic against HT-29 colon cancer cells.
Blood-cholesterol lowering
Some EPS exhibit the ability to lower blood cholesterol (Nakajima et al, 1992; Pigeon et al,
2002; Welman & Maddox, 2003; Phyo et ai, 2008). It was cited by Nakajima (1992) that the
consumption of milk fermented with an EPS-producing LAB significantly decreased serum
cholesterol levels in rats, in comparison to those that consumed milk fermented with a nonEPS producing strain. It is thought that these polymers may have the potential to interfere
with the absorption of cholesterol or of bile acids from the intestines by binding to them and
removing them from the body (Pigeon et al, 2002). Maeda et ai, (2004) carried out research
on the effects the exopolysaccharide, kefiran had in animals, and found that it suppressed the
increase of blood pressure and at the same time it reduced the serum cholesterol levels in
SHRSP/Hos rats when the rats consumed excessive dietary cholesterol. In KKAy mice, given
kefiran supplementation, demonstrated the ability to significantly lower blood glucose. When
kefiran was administered to constipated SD (Sprague Dawley) rats, an obvious improvement
in the levels of fecal moisture and wet weights of feces was observed. Uchida et al, (2010)
carried out research on the same EPS kefiran using a rabbit feeding trial to investigate their
antiatherogenic effect when fed a high-cholesterol diet. It was found that when kefiran was
administered orally it was absorbed into the blood. It prevented the onset and development of
atherosclerosis in hypercholesterolemic rabbits by anti-inflammatory and anti-oxidant
actions.
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Anti-ulcer activity
EPS-producing LAB have also been claimed to have beneficial effects such as
immunostimulatory/antiulcer (Nagaoka et al, 1994) effects in the host. Research carried out
by Nagaoka et al, (1994) reported certain antiulcer effects of EPS produced by
bifidobacteria, lactobacilli, and streptococci strains. Research carried out by Rodriguez et al,
(2009) studied the potential preventive effect fermented milks (FM) with EPS-producing
Streptococcus thermophilus strains (CRE 1190 and CRL 804) on an in vivo model of chronic
gastritis. Findings from this study showed that FM with Strep, thermophilus CRL 1190 or its
EPS could be added to novel functional foods as a way of preventing chronic gastritis.
Immune system
Research by Kitazawa et al, (1992) illustrated that EPS produced by Lactococcus lactis spp.
cremoris KVS20 was able to stimulate the mitogenic response in murine spleen cells of
C57BL/6 mice. Later research carried out by Kitazawa et al, (1998) stated that the phosphate
content of an EPS may have a direct relationship with the magnitude of mitogenic activity for
this EPS. Recent results from research carried out by Targosz et al., (2006) showed that
lipopolysaccharide (EPS) derived from Gram-negative Escherichia coli-primQd macrophages
decrease their ability to bind EPS whereas EPS derived from Gram-positive Lactobacillus
rhamno.sus-‘dc\\vdiitd macrophages maintain or even increase their ability to bind EPS. These
results may suggest that in vivo commensal enteric bacteria, such as lactobacilli, will boost
the defense potential of local macrophages against pathogens expressing EPS. Vinderola et
al, (2006) found that the exopolysaccharide produced by Lactobacillus kefiranofaciens
induced a gut mucosal response and it was able to up and down regulate it for protective
immunity, maintaining intestinal homeostasis, enhancing the IgA production at both the small
and large intestine level and influencing the systemic immunity through the cytokines
released to the circulating blood.

Concluding Remarks
There are a large variety of EPS synthesized by LAB and other bacteria. Each of these has a
different chemical composition and structure. As a result, they have a number of uses, as
purified EPS in food ingredients, as in situ production of EPS in fermented foods and as non
food applications. The importance of the LAB EPS was further brought to light due to the
suggestion that they could in fact exert a beneficial effect on human health (Salazar et al.
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2008). These properties have made LAB EPS a major focus of research interest in recent
years, to capitalize fully on their potential.
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Chapter 2
Establishment of methodology for exopolysaccharide
production from lactic acid bacteria
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Abstract
In this study, two strains of lactic acid bacteria (LAB) namely Weissella kimchii F28 and W.
confusa MGl were used for the production of exopolysaccharides (EPS) from sucrose. Both
strains produced glucan polysaccharides. In the case of W. kimchii F28, the EPS isolation
procedure was performed six times, making modifications in order to optimize the yield of
EPS. The maximum yield of EPS for this strain was 16 g per litre of culture. In the case of W.
confusa MGl, the EPS isolation procedure was followed five times, resulting in a maximum
yield of EPS for this strain of 34.4 g per litre of culture. This is a substantial yield for both
strains, and permits large-scale production of EPS for various applications.
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Introduction
Lactic acid bacteria (LAB) are Gram-positive, non sporulating cocci or rods. They are
catalase and oxidase negative, anaero/aerotolerant and produce lactic acid as the major
rretabolite of carbohydrate fermentation. They generally have complex nutritional
requirements, especially for amino acids and vitamins. The genera that eomprise the LAB are

Lactobacillus, Lactococcus, Leuconostoc, Pediococcus, Streptococcus, as well as the more
peripheral Enterococcus and Weissella genera (Fran9oise, 2010). Previous studies have also
shown that certain strains of Bifidobacterium are also able to produee these biopolymers
(Abbad-Andaloussi et ai, 1995; Roberts et ai, 1995; Hosono et ai, 1997; Ruas-Madiedo et

a'.., 2005). LAB are widespread in nature and eommonly found in many food produets (dairy,
rr eat, fruit, vegetables, etc.), as well as in the genital, intestinal and oral eavities of animals
and humans (Fran9oise, 2010).
Extracellular polysaccharides (exopolysaceharides) (EPS) are commonly found in bacteria
and microalgae and less frequently in yeasts and fungi. Several LAB are known to produce
these substances (De Vuyst & Degeest, 1999; Ruiz-Herrera, 1991; Welman & Maddox, 2003;
van Flijum et ai, 2006). EPS are long-chained polysaccharides, whieh consist of branched,
repeating units of sugars or sugar derivatives. These sugars units are mainly glueose,
galactose and rhamnose in different ratios (De Vuyst & Degeest, 1999; Welman & Maddox,
2003). EPS produced by bacteria are not used as an energy source by these bacteria (RuasMadiedo et ai, 2002); they are, in fact, thought to have a beneficial effect on human health
with the potential of acting as prebiotics when consumed. Prebioties are compounds, usually
carbohydrates, whieh are resistant to direct metabolism by the host and reach the caecoeolon, where they are preferentially utilized by selected groups of beneficial bacteria (Ziemer
& Gibson, 1998; Li et ai, 2008).
Depending on their chemical composition and mechanism of biosynthesis, EPS can be
divided into two categories: heteropolysaccharides and homopolysaceharides (De Vuyst &
Degeest, 1999; van Hijum et ai, 2006). Heteropolysaceharides (HePS) are eomprised of
repeating units of different monosaceharides; the monosaccharides are present as a-or (3anomer in the pyranose or furanose form (De Vuyst et al, 2001). Homopolysaccharides
(HoPS) contains a single type monosaccharide, fructose or glucose, the fructans and the
glucans, respectively (van Hijum et ai, 2006; Monsan et al., 2001). They consist of four
subgroups, (a) a-D-glucans, i. e. dextrans {Leuconostoc mesenteroides subsp. mesenteroides
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and Leuc. mesenteroides subsp. dextranicum), mainly composed of a-1, 6-linked glucose
residues, (b) p-D-glucans, composed of p-1, 3-linked glucose molecules with (3-1, 2-branches,
(c) fructans, composed of P-2, 6-linked D-fructose molecules and (d) others, e.g.
polygalactan, composed of structurally identical repeating units with different glycosidic
linkages (De Vuyst & Degeest, 1999).
The objective of this study was to outline the development of the methodology for large scale
production of exopolysaccharides from lactic acid bacteria.

Figure 1. EPS molecular structures showing monosaccharide residues joined by a-1,
6 and a-1, 4-bonds (top), and residues linked by p-1, 4-bonds (bottom) (Copper,
2000).
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Selection of EPS producing LAB
Table 1. EPS-producing LAB available from collaborators with species identification, origin
of bacterium, carbon source required for EPS production and approximate yield of EPS.
Species

Strain origin

Carbon source

Lb. reuteri aalP
Lb. reuteri col
Lb. reuteri ff2(hh2)
Lb. reuteri VIP
Lb. reuteri Y2
W. kimchii F28
W. kimchii F33
W. confusa MGl
W. confusa MG7
Lb. casei C12
Lb. casei C13
Lb. sanfrancisencis
1729
Lb. sanfrancisencis
2590

Porcine
Porcine
Porcine
Porcine
Porcine
Sourdough
Sourdough
Sourdough
Sourdough
Cheese
Cheese
Sourdough

Sucrose
Sucrose
Sucrose
Sucrose
Sucrose
Sucrose
Sucrose
Sucrose
Sucrose
Sucrose
Sucrose
Sucrose

and maltose
and glucose

EPS yield
(g/l)
1.71+/-0.19
2.05+/-0.36
3.60+/-0.55
3.35+/-0.79
2.27+/-0.49
16.21+/-1.75
13.44+/-6.13
36.40+/-0.55
13.69+/-1.82
0.79+/-0.31
0.66+/-0.34
2.79+/-0.40

Sourdough

Sucrose and glucose

2.57+/-0.69

and
and
and
and

maltose
maltose
maltose
maltose

On the basis of levels of EPS produced, Weissella kimchii F28 and Weissella confusa MGl
were chosen for large scale EPS production. Strain MGl produces glucans from glucose with
a molecular weight of 5x10^-4x10^ Da. This EPS could be digested by dextranase,
hydrolyzing a-(l-6)-a-glucosidic linkage. Strain F28 produces glucans from glucose with a
molecular weight of 5x10^-4x10^ Da. This EPS could be digested by dextranase, hydrolyzing
a-(l-6)-a-glucosidic linkage. These EPSs were designated EPSmgi and EPSf28-

Materials and Methods
This chapter is concerned with the set-up of new methodology for production of EPS from
LAB. Thus results of this chapter outline the final methodology.

Results
Growth medium for enhancement of EPS production
EPS-production by lactic acid bacteria could be clearly observed on MRS agar plates
containing sucrose. A typical example is shown in Figure 2.
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Figure 2. EPS production by LAB on MRS agar with and without 10% sucrose. A:
EPS producer on MRS (no sucrose). B: EPS producer on MRS-sucrose.
EPS of the species mentioned above were isolated by growing at 30

for 24-48 h; however,

for some species a different incubation temperature may be needed for optimum growth.
Initially volumes of 200 ml were first used but the typical volume used was 2 L. EPS of the
species mentioned were isolated by growing in the following medium, containing 10% of
sucrose.
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Table 2. EPS broth composition. After all the ingredients were added distilled water
was added to bring it to a final volume of 1,000 ml.
Ingredients

Supplier

Amount per litre

Peptone

Fluka

10.00 g

Yeast extract

Fluka

5.00 g

Meat extract

Fluka

5.00 g

K2HPO43H2O

Sigma

2.60 g

KH2PO4

Sigma

4.00 g

Cysteine HCl

Fluka

0.50 g

NH4CI

Sigma

3.00 g

Sucrose*

Sigma

100.00 g

Tween

Sigma

1.00 ml

MgS04.7H20

Fluka

O.lOg

MnS04.H20

Fluka

0.05 g

Vitamin mix**

See below

1.00 ml

*Sucrose: This sugar was made up separately: (20 g plus 20 ml H2O) and autoclaved
separately to prevent mallard reaction. This was then added to the rest of the ingredients. For
smaller volumes, the above method was scaled down.
** Vitamin Mix: containing per litre: 0.2 g cobalamin (Sigma), 0.2 g folic acid (Sigma), 0.2 g
nicotinic acid aminde (Sigma), 0.2 g pantothenic acid, 0.2 g pyridoxal phosphate (Sigma) and
0.2 g thiamine (Sigma), sterilized by filtration. This was dispensed in 1 ml volumes and
stored at -20 ”C. The appropriate volume was then added to the cooled broth.
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Incubation of LAB at 30 C

Refrigerated Centrifuge

I

Storage at 4”C

v
/

Dialysis

Lyophilisation
Figure 2.0verview of EPS production
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Small-scale EPS production
EPS of Weissella confusa MGl and Weissella kimchii F28 were isolated as follows,
1. Strains were grown at 30 °C for 48 h in 200 ml modified MRS broth, to allow for
optimum growth. Growth for 24 h was attempted initially but it was found that this
time-scale did not permit optimal growth. In instances where the fully-grown EPS
culture was viscous in nature, an equal volume of sterile water was added.
2. The culture supernatant was obtained by centrifugation (20 min, 9,800 rpm, 4 ®C).
This was poured into a graduated cylinder and the volume was recorded. Following
this it was poured into sterile 1 L bottles (not exceeding 250 ml). Three volumes of
ice-cold ethanol were then added using the same graduating cylinder and the mixture
was kept at 4 °C for 24 h (+/- 3 h as necessary). If using different strains it is
necessary to use different graduating cylinders to prevent cross contamination.
3. EPS was harvested by centrifugation (20 min, 11,300 rpm, 4 °C). The precipitate was
dissolved in 50 ml distilled water. Importantly, EPS pellets are frequently difficult to
resuspend and it may be necessary to add additional water with vortexing (keep sterile
water to a minimum).
4. The EPS solution was dialyzed against demineralised water at 4 °C for 24 h.
Membrane was obtained from Spectra Labs (0031 765719419), (6 Spectra/Por
Dialysis Membrane, molecular weight cut-offs (MWCO); 10,000, Flat width: 32 mm,
Diameter: 20.4 mm, vol/length: 3.3 ml/cm). This was cut to satisfactory lengths and
placed in the water for 30 min prior to use. Latex gloves were worn when handling
the membrane. To optimise dialysis, the water volume exceeded 100 L. It was
necessary to keep this water clean and initially, dialysis was carried out for 24 h but in
some cases up to 48 h-96 h was needed.
5. The dialyzed EPS was then lyophilised. The sample was removed from the dialysis
tubing using a scissors previously sterilised using ethanol. It was poured into a freezedrier receptacle (previously washed and sterilised using ethanol) or a 50 ml centrifuge
tube standing upright with the cap removed. This process can take up to 2-3 days.
Typically, a larger volume would be completed in 4-5 days. It was possible to check if
all the liquid had been removed by touching the bottom of the container and, if cold
then liquid still remains.
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6. The lyophilised EPS was then weighed and stored at room temperature until required.
The yield of EPS was calculated for each strain, based on the volume of original
sample.
The above methodology applies to EPS production from a 200 ml culture. For largerscale production, a 2 L bacterial culture was recommended and the volumes of reagents
were increased accordingly. Typical yields are shown in Tables 3 and 4.
Table 3. Yields of EPS obtained for cultures of Weissella confusa MGl
Batch
No.
1

Producer
Strain
MGl

Culture
Volume
200 ml

Yield (g)
2.352

Non-viscous

2

MGl

200 ml

2.352

Non-viscous

3

MGl

1 L

32.400

4

MGl

1 L

34.400

5

MGl

2L

65.400

MGl

Total yield

136.900

Observations

Viscous, equal volumes
of water was added at
step 1 of the protocol
Viscous, equal volumes
of water was added at
step 1 of the protocol
Viscous, equal volumes
of water was added at
step 1 of the protocol

Table 4. Yields of EPS obtained for cultures of Weissella kimchii F28
Batch
No.
1

Producer
Strain
F28

Culture
Volume
200 ml

2

F28

3

Yield (g)

Observations

1.476

Non viscous

200 ml

1.476

Non viscous

F28

1 L

15.210

4

F28

1 L

16.000

5

F28

2L

30.400

6

F28

2L

29.400

F28

Total yield

93.960

Viscous, equal volumes
of water was added at step
1 of the protocol
Viscous, equal volumes
of water was added at step
1 of the protocol
Viscous, equal volumes
of water was added at step
1 of the protocol
Viscous, equal volumes
of water was added at step
1 of the protocol
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Discussion
In this study, two strains of sourdough LAB were used for the production of EPS from
sucrose. Both strains produced glucans, which are formed from sucrose by the activity of a
single enzyme i.e. glucansucrase (De Vuyst & Degeest, 1999; van Hijum et al., 2006).
Production of EPS from sucrose is a metabolic activity that is widespread among sourdough
LAB (Ticking et al, 2003). Two isolates of LAB were used for EPS production, namely

Weissella kimchii F28 and W. confusa MGl. In the case of EPSf28, the EPS isolation
procedure was performed six times, making minimum modifications in order to optimize the
yield of EPS. The maximum yield of EPS for this strain was 16 g per litre of culture. In the
case of EPSmgi, the EPS isolation procedure was followed five times, making minimum
modifications in order to optimize the yield of EPS. The maximum yield of EPS for this
strain was 34.4 g per litre of culture. By any standards, this is a very substantial yield of
polysaccharide. Typical modifications to the protocol included extending the incubation time,
increasing the culture volume and extending the lyophilisation time. EPS from LAB have
many uses, one of which is to improve the textural properties of fermented foods (Ticking et

al., 2003). De Vuyst & Degeest (1999) suggested that the health promoting effect of these
EPS-production strains are in fact related to the biological activities of these biopolymers.
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Chapter 3
Establishment of parameters for murine feeding of
exopolysaccharides
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Abstract
Animal feeding trials are an important prerequisite for the evaluation of prebiotic potential of
novel ingredients. This study was established to define the parameters for mouse feeding
trials with two novel microbial polysaccharides. Factors examined included basal diet
composition, the best duration of the feeding trial to obtain results, animal housing, sampling
methodologies and analytical microbiology methodologies. Following determination of the
optimum conditions for these parameters, a system was designed which permitted the feeding
trial to progress successfully.
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Introduction
It has been found that microbial communities of considerable biodiversity populate the large
bowels of animals, including humans, and influence the physiology, biochemistry and
immunology of the animal host. It has been suggested that altering the bacterial activities in
the bowel could in fact promote the general health of humans or be used in the prophylaxis or
treatment of specific diseases (Salminen et al, 1998). Despite the lack of understanding of
the ecological interactions that exist between the bacteria themselves and the animal host,
experimental data indicates that certain bacteria are believed to benefit the host, whereas
others may be harmful, due to production of toxins and genotoxic metabolites or mucosal
invasion (Salminen et al, 1998). Ingestion of prebiotics are one way in which a positive
effect on the composition of the intestinal microflora and their metabolic activity can be
achieved (Bello et al, 2001). The term “prebiotics” has been defined as a nondigestible food
ingredient that beneficially affects the host by selectively stimulating the growth and/or
activity of one or a limited number of bacteria in the colon that can improve the host health
(Gibson, 1999). Inulin is one example of a well-characterized prebiotic, which has been
shown to stimulate the growth of bifidobacteria in several well-designed in vitro studies using
either pure bacterial cultures or undefined cultures of G1 origin (Apajalahti et al, 2002). It is
a fructo-oligomer which can be isolated from plants such as chicory.
Bacterial exopolysaccharides have also been classified as potential prebiotics. They are
commonly found in bacteria and microalgae and less frequently in yeasts and fungi (van
Hijum et al, 2006). Several lactic acid bacteria (LAB) are known to produce EPS (van Hijum
et al, 2006), many of which have beneficial effects on rheological properties of fermented
dairy products such as yogurts. For this reason, interest in EPS-producing LAB and their
important role in the dairy industry have increased (Kimmel et al, 1998; Ruas-Madiedo et
al, 2002).
Lactie acid bacteria (LAB) which produce exopolysaccharides (EPSs) play an important role
in the dairy industry because of their contribution to the consistency and rheology of
fermented milk products (Ruas-Madiedo et al, 2002). This ehapter sets out to define the
parameters necessary for a successful murine feeding trial with bacterial EPS. Typical
challenges to such an experiment include selecting the best basal diet composition from the
different diets represented in the scientific literature; the best duration of the feeding trial to
obtain results and the optimum bedding conditions.
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Materials and Methods
EPS of lactobacilli
See chapter 2. Briefly, EPS of fV. confusa MGl and Weissella kimchii F28 were isolated as
follows: Strains were grown at 30 °C for 24 h on a medium containing (per litre) 100 g
sucrose (Sigma), 10 g tryptone (Fluka), 5 g yeast extract (Fluka), 5 g beef extract (Fab Lemco
powder) ( Fluka), 3 g NH4CF (Sigma), 2.6 g sodium acetate trihydrate (Sigma), 4 g
KH2P04-3H20 (Sigma), 0.5 g cysteine HCl (Fluka), 0.1 g MgS04-7H20 (Fluka), 0.05 g
MnS04-4H20 (Fluka), 1 ml Tween 80 (Sigma). The medium was autoclaved at 121 °C for 15
min and to the cold medium a filter-sterilised vitamins solution (1 ml) was added, containing
per litre: 0.2 g cobalamin (Sigma), 0.2 g folic acid (Sigma), 0.2 g nicotinic acid aminde
(Sigma), 0.2 g pantothenic acid, 0.2 g pyridoxal phosphate (Sigma) and 0.2 g thiamine
(Sigma). The culture supernatant was obtained by centrifugation (20 min, 9,800 rpm, 4 ®C).
Three volumes of ice-cold ethanol was added and the mixture was incubated at 4 °C for 24 h.
EPS was harvested by centrifugation (20 min, 11,300 rpm, 4 °C). The precipitate was
dissolved in distilled water, dialyzed against demineralised water at 4 °C for 24 h, lyophilized
and allowed to stand at room temperature.

Media preparation
Bile Esculin Azide Agar is used for the isolation and presumptive identification of faecal

Streptococci. Bile Esculin Azide Agar is a modification of Bile Esculin Agar with the
addition of sodium azide as an inhibitor and with the reduction of the bile concentration. The
resulting medium is more selective but still provides rapid growth and efficient recovery of
enterococci. The ability to hydrolyze esculin in the presence of bile is a characteristic of
enterococci. Organisms positive for esculin hydrolysis hydrolyze the glycoside esculin to
esculetin and dextrose. The esculetin reacts with the ferric citrate to form a dark brown or
black colony. Ox bile does not inhibit enterococci, while other Gram-positive bacteria are
inhibited. Sodium azide inhibits Gram-negative bacteria. Tryptone, peptone and yeast extract
supply the nutrients essential for growth. Sodium chloride provides the osmotic balance. The
medium is made as follows; 56.65 g of Bile Esculin Azide Agar (Fluka) was dissolved in 1 L
of distilled water and autoclaved at 121°C for 15 min.
Crvoprotective medium is used to protect cell viability during frozen storage of fresh faecal
samples. Five grams of Lab-Lemo (Oxoid) and 50 ml glycerol was dissolved in 500 ml of
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distilled water. The pH was then adjusted to 7.3 and brought to final volume of 500 ml with
distilled water and then autoclaved at 110 °C for 20 min (Crowther, 1971).
MacConkev agar No3 is used for the isolation and enumeration of coliform. MacConkey agar
is a culture medium designed to grow Gram-negative bacteria and stain them for lactose
fermentation. It contains bile salts (to inhibit most Gram-positive bacteria, except
Enterococcus and some species

Staphylococcus), crystal violet dye (which also inhibits

certain Gram-positive bacteria), neutral red dye (which stains microbes fermenting lactose),
lactose and peptone. Acting as a visual pH indicator, the agar distinguishes those Gram
negative bacteria that can ferment the sugar lactose (Lac+) from those that cannot (Lac-).
This medium is also known as an "indicator medium" and a "low selective medium".
Absence of electrolytes serves to inhibit swarming by Proteus species. By utilizing the
lactose available in the medium, Lac+ bacteria such as Escherichia coli, Enterohacter and
Klebsiella will produce acid, which lowers the pH of the agar below 6.8 and results in the
appearance of red/pink colonies. Non-lactose fermenting bacteria such as Salmonella,
Proteus species. Pseudomonas aeruginosa and Shigella cannot utilize lactose, and will use
peptone instead. This forms ammonia, which raises the pH of the agar, and leads to the
formation of white/colourless colonies. The medium is made as follows; 51.5 g of
MacConkey Agar no3 (Oxoid) was dissolved in 1 L of distilled water and autoclaved at 121
°C for 15 min.
MRS agar and MRS broth were designed to encourage the growth of the LAB bacteria, which
includes species of the following genera; Lactobacillus, some Streptococcus strains,
Pediococcus and Leuconostoc. All these species can produce lactic acid in considerable
amounts. They are Gram-positive, catalase and oxidase negative and are fastidious in their
nutritional requirements. Growth is enhanced considerably by microaerobic conditions.
Generally the LAB show delayed growth and smaller colony size than other micro
organisms. They may be overgrown in non-selective media, especially if incubation is
required for 2-4 days. MRS medium is selective for lactobacilli but some growth of
leuconostocs and pediococci may occur. Selectivity can be altered by pH adjustment.
Lactobacilli will tolerate lower pH levels than streptococci (pH 5.0-6.5), with pediococci and
leuconostocs growing best within this range. Inhibitors of the main groups of competitor
microflora include thallous acetate, sodium acetate, sorbic acid, acetic acid, sodium nitrite,
cycloheximide and polymyxin. These substances can be used at varying concentrations and
combinations but, inevitably, a compromise has to be reached between selectivity and
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productivity of the organism(s) sought. The medium is made as follows; 62 g of MRS agar
(Oxoid) was dissolved in 1 L of distilled water and boiled to dissolve the medium completely,
autoclaved at 121 °C for 15 min. For broth, 52 g of MRS broth (Oxoid) was dissolved in 1
litre of distilled water at 60 °C and mixed until it was completely dissolved, and subsequently
autoclaved at 121 °C for 15 min.
Nutrient Agar is used for the isolation and enumeration of total anaerobes. Nutrient Agar
consists of peptone, beef extract and agar. This relatively simple formulation provides the
nutrients necessary for the replication of a large number of microorganisms that are not
excessively fastidious. The beef extract contains water-soluble substances including
carbohydrates, vitamins, organic nitrogen compounds and salts. Peptones are the principle
sources of organic nitrogen, particularly amino acids and long chained peptides. The medium
was made as follows; 28 g of Nutrient Agar (Fluka) was added to 1 L distilled water. This
was dissolved by bringing it to the boil, and subsequently autoclaving at 121 °C for 15 min.
Phosphate Buffer Solution (PBS). Four tablets of % strength Ringer’s solution were dissolved
in 1 L distilled water and subsequently autoclaved at 121 °C for 15 min.
Reinforced Clostridial Agar: is used for the cultivation and enumeration of Clostridia. This
medium, formulated by Hirsh and Grunstad, is superior to others in supporting growth and
producing high cell counts of Clostridia. When incubated anaerobically, this medium grows
various anaerobes and other bacteria. The peptone and beef extract are sources of nitrogen,
vitamins and amino-acids. The yeast extract provides B-complex vitamins. Dextrose is a
complex carbohydrate and sodium chloride maintains the osmotic balance. In low
concentrations, the starch detoxifies metabolic by-products. L-Cysteine hydrochloride is the
reducing agent and sodium acetate is the buffer. The medium is made as follows; 51 g of
Reinforced Clostridial Agar (Fluka) was dissolved in 1 L of distilled water and autoclaved at
121 °Cfor 15 min.
Rogosa SL agar is a selective agar for isolation and enumeration of lactobacilli and
bifidobacteria belonging to intestinal flora. This medium is selective, modified by Rogosa to
contain high levels of sodium acetate and ammonium citrate at a low pH, which inhibits most
microorganisms, including streptococci and molds and limits swarming but allows for the
growth of lactobacilli. Sacarose, arabinose and dextrose are fermentable carbohydrates as
carbon and energy sources; tryptone provides nitrogen, vitamins, minerals and amino acids;
yeast extract provides vitamins, particularly B-group and other trace elements essential for
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growth; the sulfate salts provide inorganic ions; sorbitan monooleate is a surfactant;
monopotassium phosphate is the buffer. The medium is made as follovys; 73 g of Rogosa SL
agar (Fluka) and 1 ml Tween 80 (Merck) was dissolved in 1 L of distilled water. All
components were added to a sterile 2 L conical flask and brought to the boil on a hot plate.
Following boiling the agar, 1.32 ml glacial acetic acid (Sigma) was added and brought to the
boil. This medium is not autoclaved.
Schaedler Anaerobe Broth is used for the isolation and enumeration of bacteriodes. Schaedlar
agar is a culture medium designed to support the growth of anaerobes from the intestinal and
digestive tracts and other organs, without the interference of the accompanying aerobic flora,
because of its superior nutritive properties and its low oxidation-reduction potential. In
normal conditions, the multiplication of anaerobes is diminished by the rapid increase of
enterococci, E. coli, Enterohacier and other intestinal facultative bacteria. Trypticasein soy
broth, peptone and yeast extract provide vitamins, nitrogen, and amino acids in Schaedler
Agar. Dextrose is a carbon source. Tris (Hydroxymethyl Aminomethane) is used to buffer the
medium. Hemin stimulates organism growth. L-Cystine is a reducing agent. Agar is the
solidifying agent. Schaedler can be used with various supplements for the isolation and
recovery of lactobacilli, streptococci, clostridia, Bacteroides, and Flavohacterium from feces
and contents of the intestinal tract. The medium is made as follows; 26.5 g of Schaedler
Anaerobe Broth (Oxoid) was dissolved in 1 L of distilled water and autoclaved at 121 °C for
15 min.
Wilkins-Chalgren Anaerobe Agar is used for the isolation and enumeration of total
anaerobes. Wilkins-Chalgren Agar was designed by Wilkins and Chalgren for use in
determining minimal inhibitory concentration (MIC’s) of antibiotics for anaerobic bacteria by
the agar dilution procedure. This medium was selected because it does not require the
addition of blood to support satisfactory growth of most anaerobes. Anaerobic bacteria cause
a variety of human infections including endocarditis, meningitis, wound infections following
bowel surgery or trauma, and bacteremia. The survival of anaerobic bacteria is dependent on
their sensitivity to oxygen, nutritional requirements, appropriate collection, culture medium,
and incubation time and temperature. The medium is made as follows; 43 g of WilkinsChalgren Anaerobe Agar (Oxoid) was dissolved in 1 L of distilled water and autoclaved at
121 °Cfor 15 min.
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All the above media were stored at room temperature with the exception of Rogosa SL agar
which was stored at 4 ®C.
Acquisition and storage of faecal samples
Faecal samples were retrieved from mice. Using a forceps previously cleaned with ethanol
the faecal sample was placed in cryoprotective medium. This cryoprotective medium was
pre-prepared in 1 ml volumes in 2 ml cryotubes (Sarstedt) and labelled in advance. Once
sample was in the tube it was mixed by using a vortex mixer and transported back to the lab
and stored at -80 °C.
Determination of total bacterial counts
Prior to this step, it was necessary to first calculate the dilution factor associated with placing
the faecal material in the cryoprotective medium. This was achieved by carrying out decimal
dilutions on all faecal samples. Dilutions 10 to 10 were plated out for the determination of
conforms on MacConkey agar. Dilutions lO"^ to 10'^ were plated out for the determination of
Lactobacillus and Bifidobacterium on Rogosa Agar. Dilutions of 10' to 10' were plated out
for the determination of total anaerobes on Wilkins-Chalgren Anaerobe Agar and for the
determination of Clostridia on Reinforced Clostridial Agar (RCA). Dilutions of 10'* to 10'^
were plated out for the determination of total anaerobes on Nutrient Agar and for the
determination of streptococci on Bile Esculin Azide Agar (BEAA). All serial dilutions were
performed in the anaerobic cabinet under the same conditions and faecal samples were
allowed to defrost on ice prior to starting the dilution series. Nine hundred microliters of PBS
was added to several 1.5 ml microcentrifuge tubes (Fischer) and into the first 100 pi of
sample (10'^) was added. This was then vortexed and 100 pi was taken from it and aseptically
transferred into the next tube (10 ) and mixed by using a vortex mixer. This procedure was
repeated up to 10'^. Following the completion of the serial dilutions, 100 pi of each of the
selected dilutions were plated, spread via Colirollers^'^ plating beads (Merck) and incubated
at 37 °C.
Methodology for bead spread plating (Novagen)
ColiRollers™ Plating Beads offer a better way to perform routine procedure-plating bacteria.
Typical plating methods use a bent glass rod "hockey stick," which must be immersed in 70%
ethanol and flamed between uses, or disposable plastic applicators. Both require vigorous
spreading while rotating the plate. These older methods can become extremely laborious and
time consuming when processing many samples, and can produce inconsistent results, due to
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differences in pressure applied, length of rotation time, and moisture content of the plates.
Novagen ColiRollers^*^ Plating Beads are specially treated glass beads that facilitate
spreading.
To the plate 100 pi of the cell suspension was added. Ten-twenty beads were added to the
plate, which was then moved back and forth several times. This rolling action was performed
up to 10 times, or until the plate appeared dry. The rolling action of the sterile beads gently
spreads the cells evenly and completely over the agar surface. Entire stacks of plates are
processed at one time. After plating, the beads are shaken off the plate and placed into 70%
ethanol solution. The plates were then incubated. Bead sterilization was achieved by allowing
the beads to stand in the 70% ethanol solution for up to 24 h. The ethanol was then removed
and the beads were washed. Beads were then placed into a container and placed in an
incubator to dry for 2-3 days. Once removed, the beads were autoclaved at 121 °C for 15
min. ColiRollers*^'^ beads are available sterile and each package contains enough beads for 60
to 80 plates.

Figure 1. ColiRollers^''^ beads spread the cells evenly and completely over the agar
surface by moving the plate back and forth a number of times.
In the case of lactobacilli and bifidobacteria, these plates were held under anaerobic
conditions in the anaerobic cabinet for 48 h (lactobacilli) and 96 h (bifidobacteria) and in the
case of conforms, aerobically for 24 h. Colonies were then enumerated and results were
documented.
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Results
Murine diet compositions
For murine feeding trials AIN-93M was used as the basal diet. This was purchased from
Lillico, Betchworth, United Kingdom (Tel) 01622718062. The ingredients of AIN-93M are
shown in Table 1.
Table 1. Formulation of the AIN-93M diet for maintenance of rodents when casein is
used as the protein source (Reeves, 1997; Abdel-Rahman et ai, 2009).

Ingredients

g/kg diet

Cornstarch

465.69

Casein (>85% protein)

140.00

Dextrinized cornstarch (90-94%
tetrasaccharides)

155.00

Sucrose

100.00

Soybean oil (no additives)

40.00

Fiber

50.00

Mineral mix (AIN93G-MX)

35.00

Vitamin mix (AIN93-VX)

10.00

L-Cystine

1.80

Choline bitartrate (41.1% choline)

2.50

/er/-Butylhydroquinone (TBHQ), mg

8.00

It was found that A1N-93M was causing bloating in the stomach of the animals, and for this
reason this basal diet could not be used. AIN- 93M diet has a lower protein and fat content
and is therefore recommended for adult maintenance. It was then decided to use AIN-93G
diet, which is recommended to support growth, pregnancy and lactation phases (Reeves,
1993). The ingredients for this diet can be seen in Table 2.
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Table 2. Formulation of the AIN-93G diet for rapid growth when casein is used as the
protein source (Reeves, 1997).

Ingredients

g/kg diet

Cornstarch

397.49

Casein (>85% protein)

200.00

Dextrinized cornstarch (90-94%
tetrasaccharides)

132.00

Sucrose

100.00

Soybean oil (no additives)

70.00

Fiber

50.00

Mineral mix (AIN93G-MX)

35.00

Vitamin mix (AIN93-VX)

10.00

L-Cystine

3.00

Choline bitartrate (41.1 % choline)

2.50

/cr/-Butylhydroquinone (TBHQ), mg,

14.00

Preliminary mouse feeding trials
A number of sequential feeding trials were run, modifying various parameters based on the
findings of the previous trial in each case.

Figure 2. Example of a CDl Mouse.
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Mouse feeding trial 1 (Date: 23/3/09)
Reason for the trial: To determine if a difference occurred between the normal feed and the
basal diet and subsequently analyse the samples by comparing when the samples were frozen
and when they were fresh.
Species of mouse: Female CDl mice (17-24 days old)
Nos of animals per group: 2 animals per diet
Basal Diet fed: A1N-93M
Amounts of EPS fed: None
Timespan: Over a week
Analyses completed: Stomach, ileum, caecum, proximal and distal colon were dissected from
each mouse. The faecal samples of each mouse were also collected and serial dilutions were
carried out. These were then placed on Rogosa (lactobacilli and bifidobacteria), nutrient (total
anaerobes), and RCA (reinforced Clostridia agar for clostridia) to determine bacterial counts.
Outcome: Basal diet used was determined to be not suitable. On dissection it could be seen
that the stomach of the mouse fed the basal diet was extended and full of gas/ liquid, on
looking at the spleen no infection could be seen. The caecum appeared much smaller and it
was difficult to distinguish between proximal and distal colon. It was concluded that frozen
samples were acceptable, as minimal cell death occurred.
Mouse feeding trial 2 (Date: 7/4/09)
Reason for the trial: Mice were fed 2 diets (A1N-93M and RM-3) and a comparison was
made to determine the difference between mice under normal bedding conditions and mice
with a wire base. The caecum was dissected from each mouse.
Changes made between this (2) trial and trial 1: Nine ml PBS plus 1 ml sample was used,
where as in the first trial 900 pi PBS plus 100 pi sample was used. Glass beads were used to
spread the bacteria on the plates instead of the hockey stick.
Species of mouse: Female CDl mice (17-24 days old)
Nos of animals per group: 2 mice/grp (group 1: wire base, diet AIN-93M, group 2: bedding,
diet AIN-93M, group 3: bedding, diet RM3, group 4: wire base, diet RM3).
Basal Diet fed: A1N-93M
Amounts of EPS fed: None
Timespan: Over a week
Analyses completed: Caecum was dissected from each mouse and plated on nutrient, RCA,
BEAA and MacConkey agar (for coliforms) to determine bacterial counts.
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Outcome: It was evident that use of a wire base, was optimal as it prevented the mice from
eating their own faeces. It was also established the six mice/cage was optimal.
Mouse feeding trial 3 (Date: 3/6/09)
Reason for the trial: To determine the bacterial counts in caecum material and if possible to
obtain an explanation for the bloating in the stomach of the mice.
Species of mouse: Female CDl mice (17-24 days old)
Nos of animals per group: 3 mice involved
Basal Diet fed: AIN-93M
Amounts of EPS fed: None
Timespan: Over a week
Analyses completed: Ileum, stomach, caecum, proximal and distal colon were dissected and
faeces taken and plated on BEAA, MacConkey, Schedlar (bacteriodes), RCA ,Wilkins
Chalgren (total anaerobes) and Rogosa agar to determine bacterial counts.
Outcome: It appeared that the bacteria were been affected by air so no further work was
carried out until an anaerobic tent was obtained. It was decided that an anaerobic tent would
give better reproducible data. It appeared that A1N-93M was causing bloating, despite the
fact that it was used in trials in the literature. Therefore it was decided to use A1N-93G diet
which is recommended to support growth, pregnancy and lactation phases, whereas AIN93M diet has a lower protein and fat content and is recommended for adult maintenance
(Reeves et al., 1993).
Mouse feeding trial 4 (Dates: 15/06/09- 29-6/09)
Reasons for the trial: To evaluate the new basal diet (A1N-93G). To determine the effect that
5% inulin, 5% EPSf28 and 5% EPSmgi supplements would have on the gut microflora.
Species of mouse: Female CDl mice (17-24 days old)
Nos of animals per group: 3 mice per group
Basal Diet fed: A1N-93G
Amounts of EPS fed: 5%
Time span: 14-days
Analyses completed: The caecum was dissected and faeces were obtained from each mouse
and plated on Rogosa agar for lactobacilli and bifidobacteria counts.
Outcome: AIN-93G diet was better than AIN-93M, causing no discomfort. It was decided
that 5% of EPSs appeared to be appropriate (edible). Recommendations for an anaerobic tent
were strongly supported.
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Mouse feeding trial 5 (Dates: 9/11/09 - 23/11/09)
Reason for the trial: Characterization of the effect of exopolysaccharides on the level of
Lactobacillus, Bifidobacterium and coliform^’ on murine gut micro flora.
Species of mouse: Female CDl mice (17-24 days old)
Nos of animals per group: 6 mice per group
Basal Diet fed: A1N-93G
Amounts of EPS fed: 5% of each EPS
Time span: 14-days
Analyses completed: Initially analysis (triplicate) was carried out using Rogosa for
bifidobacteria and lactobacilli. MacConkey agar was used for the enumeration of coliforms
present.
Outcome: Specific counts from different diets were obtained and analyse was carried out to
see if the EPSs used had any influence on the populations of Lactobacillus, bifidobacteria and
conforms in the murine gut.
The results of this final trial are described in detail in Chapter 4.

Discussion
The aim of this study was to determine the parameters necessary for a successful murine
feeding trial with bacterial EPS by carrying out a number of pre-trials. It is generally accepted
that the mouse is a good animal model for studying interactions between the gut microbes
and the host, since the mouse is the best studied of the intestinal ecosystems of monogastric
animals. Although there are some anatomical differences in the gastrointestinal tracts of mice
and humans, the faecal bacterial populations of the major groups of bacteria are similar and
hence, it is suggested that the mouse could be considered an animal model to study the
dietary impact on the population of colonic bacteria (Wang et ai, 2002). In in vivo, the
micro-organisms that survive in the mice bowel have been studied recently and it is for this
reason that the mouse provides an excellent model to determine the effect of diet on the
microbial populations of the gastrointestinal tract (Santos et al, 2005).
In feeding trial 1, no differences were observed in the number of total anaerobes, lactobacilli,
bifidobacteria and Clostridia between food normally used in the animal home and AIN-93M
basal diet, so as a result no real comparison could be made. It was found, on dissection, that
the stomach of a mouse which had been fed the basal diet was swollen and full of gas and
liquid. Examination of the spleen indicated that no infection was present, indicating that the
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bloating was not due to a bacterial infection. The caecum appeared much smaller than normal
and it was difficult to distinguish between proximal and distal colon. Further investigation of
this bloating of the stomach was addressed in trial 3. It was concluded that the frozen samples
were acceptable as minimal cell death would occur in the presence of cryoprotective medium.
In feeding trial 2, the data from the bacteriological analyses suggested that the use of a wire
base was more effective than bedding. The benefit of this is that it prevented the mice, which
are copraphyic, from eating their own faeces. In feeding trial 3, the bacterial counts in
caecum material were determined. It was found that exposure to oxygen was having
detrimental effects on cell recovery and thus it was decided that anaerobic conditions would
give more reproducible data. The basis for the bloating of the stomach observed in some mice
was determined. It appeared the basal diet AIN-93M was causing bloating, despite the fact
that it was used in murine feeding trials in the literature. Therefore it was decided to use AIN93G diet, which is recommended to support growth, pregnancy and lactation phases of
growth. Generally, mice reach adulthood at the age of 7-weeks (young adults) (Personal
communication with Enforce Laboratories, Cork and Charles River Laboratories, Mayo), fhe
AIN-93 M diet has a lower protein and fat content and is recommended only for adult
maintenance (Reeves et ai, 1993). In feeding trial 4, the new basal diet (AIN-93G) and 5%
inulin, 5% EPSp28 and 5% EPSmgi supplements were used to evaluate the effect they would
have on the gut microflora. The AIN-93G diet was more suitable than AIN-93M, causing no
discomfort or bloating in animals. The 5% level of EPS used in this trial was adhered to
subsequently as it did not cause any problems with respect to reconstitution with the basal
diet and acceptability to the animals. This trial also supported the need for an anaerobic tent,
due to the anaerobic nature of bifidobacteria.
The conclusions that were drawn from each of these preliminary trails enabled the main
feeding trial to be set up. The parameters included twenty four CDl mice (17-24 days old).
The mice were randomly divided into four groups of six mice and were housed one group per
cage with a wire grid on base of cage and fed one of the following four diets: basal diet alone
(AIN-93G), basal diet plus 5% inulin (positive group), basal diet plus 5% EPSf28 (F28 group)
and basal diet plus 5% EPSmgi (MGl group). The dietary treatments were to last for 14-days.
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Chapter 4
Influence of two novel exopolysaccharides from lactic acid
bacteria on murine gut microflora
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Abstract
This study was carried out to evaluate the effects of two a-glucan exopolysaccharides (EPS)
isolated from Weissella kimchii F28 and Weissella confusa MGl on the bacterial population
of the gastrointestinal (GIT) of mice, most specifically the populations of Lactobacillus,
Bifidobacterium and coliforms. Twenty four mice were fed four different diets over a 14-day
period to determine what effect each diet may have on these populations. The basal (control)
diet was AIN-93G, the remaining thee diets consisted of basal diet and either 5% inulin, 5%
EPSf28 or 5% EPSmgi- Faecal samples were collected on days 0, 4, 8, 11 and 14, and,

following the trial, two animals from each group were randomly slaughtered and samples
were collected from the stomach, ileum, caecum, proximal colon and distal colon. The
influence of the EPS diets on Lactobacillus, Bifidobacterium and coliform numbers was
determined by carry ing out microbial cell counts. These results indicated that neither EPS
diet had an effect on lactobacilli counts or coliform counts. It was seen, however, that the
levels of bifidobacteria were considerably more pronounced in cultures containing EPSmgi
than in the other 3 diets. Denaturing gradient gel electrophoresis (DGGE) was carried out to
see if there were any fluctuations or changes within the Lactobacillus population through the
use of species specific PCR primers that targeted the V2-V3 region of the 16S rRNA gene. A
slight change in the Lactobacillus population was seen. In both EPS diets, L. intestinalis
appeared to be a stable member of the Lactobacillus population.
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Introduction
The gastrointestinal tract of mammals is colonized by a complex collection of
microorganisms (the gut microflora), of which members of the genus Lactobacillus are
considered important. These bacteria are predominant in the proximal (gastric) regions of
animals such as pigs, chickens, mice and rats (Walter et al, 2005; Walter et al, 2007). One
of the main reasons for this bacterial species found in the colon is the multiplicity of different
complex carbon sources to which they have access (Crittenden, 1999). In the last two
decades, there has been major interest in influencing the composition of the gut microbiota to
make a more health-promoting microbial community. One possibility relies on the use of
selected non-digestible dietary supplements (prebiotics), which stimulate the growth of
beneficial microbes in the gut (Tuohy et al., 2003). EPS have recently been shown to exert
beneficial effects on human health (Salazar et al., 2008). EPS are long-chained
polysaccharides which consist of branched, repeating units of sugars or sugar derivatives (De
Vuyst & Degeest, 1999; Welman & Maddox, 2003). They are commonly produced by
bacteria. Several lactic acid bacteria (LAB) are known to produce these substances (De Vuyst
& Degeest, 1999; Ruiz-Herrera, 1991; Welman & Maddox, 2003; van Hijum et al., 2006). It
has been reported in animal studies that when EPS have been used as nutritional supplements,
they reduce blood pressure (Maeda et al., 2004) and also had the ability to lower blood
cholesterol (Nakajima et al, 1992; Pigeon et al., 2002; Welman & Maddox, 2003; Phyo,
2008). The aim of this study was firstly to examine the impact of EPS on Lactobacillus,
Bifidobacterium and coliform populations using bacteriological culture on selective media. In
addition, molecular typing by PCR-DGGE was used to assess specific changes occurring
within the Lactobacillus populations.

Materials and Methods
EPS of lactobacilli
EPSf28 and EPSmgi were isolated as follows: Strains were grown at 30 °C for 24 h on a
medium containing (per litre) 100 g sucrose (Sigma), 10 g tryptone (Fluka), 5 g yeast extract
(Fluka), 5 g beef extract (Lab Lemco powder) ( Fluka), 3 g NH4CL (Sigma), 2.6 g sodium
acetate trihydrate (Sigma), 4 g KH2P04-3H20 (Sigma), 0.5 g cysteine HCl (Fluka), 0.1 g
MgS04-7H20 (Fluka), 0.05 g MnS04-4H20 (Fluka), 1 ml Tween 80 (Sigma). The medium
was autoclaved at 121 °C for 15 min and to the cold medium, a filter-sterilised vitamin
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solution (1 ml) was added containing per litre: 0.2 g cobalamin (Sigma), 0.2 g folic acid
(Sigma), 0.2 g nicotinic acid aminde (Sigma), 0.2 g pantothenic acid, 0.2 g pyridoxal
phosphate (Sigma) and 0.2 g thiamine (Sigma). The culture supernatant was obtained by
centrifugation (20 min, 9,800 rpm, 4 °C). Thee volumes of ice-cold ethanol was added and
the mixture was incubated at 4 °C for 24 h. EPS was harvested by centrifugation (20 min,
11,300 rpm, 4 °C). The precipitate was dissolved in distilled water, dialyzed against
demineralised water at 4 °C for 24 h, lyophilized and stand at room temperature.
Diets
The basal diet, the AIN-93G synthetic meal rodent diet, which is designed to meet gestation,
lactation, and growth requirements, was purchased from Lillico (Betchworth, United
Kingdom). The prebiotic used was an oligofructose-enriched inulin (Raftilose Synergy 1),
provided by ORAFTl (Tienen, Belgium). Raftilose Synergy 1 is a 1/1 mixture of long-chain
and short-chain fractions of inulin, a B (2-1 )-fructan extracted from chicory roots {Cichorium
intybus) as described elsewhere (Lesniewska et al, 2006).
Table 1: Composition of animal feed (g/kg diet) (Reeves, 1997)
Ingredients

g/kg diet

Cornstarch

397.49

Casein (>85% protein)

200.00

Dextrinized cornstarch (90-94%
tetrasaccharides)
Sucrose

132.00
100.00

Soybean oil (no additives)

70.00

Fiber

50.00

Meral mix (AIN93G-MX)

35.00

Vitam mix (AIN93-VX)

10.00

L-Cystine

3.00

Choline bitartrate (41.1% choline)

2.50

/er/-Butylhydroquinone (TBHQ), mg

14.00
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Mouse specifications and feeding conditions
Twenty four CDl mice (17-24 days old) were reared in plastic cages in a temperature-and
humidity-controlled animal facility with a 12 h light-dark cycle. The animals had free access
to feed and water throughout the experiment. The mice were randomly divided into four
groups of six mice and were housed one group per cage with a wire grid on base of cage and
fed one of the following four diets: basal diet alone (AIN-93G), basal diet + 5% inulin
(positive group), basal diet + 5% EPSf28 and basal diet + 5% EPSmgi- The dietary treatments
lasted for 14-days. The body weights and food intake of the mice were recorded on faecal
collection days.
Faecal sampling from mice
On days 0, 4,8,11 and 14, faecal samples were collected from each mouse for the isolation
and enumeration of bacteria. They were placed in 1 ml cryoprotective media and stored at -80
“C. The body weights of each mouse were recorded on faecal collection days. On the 15 th
day of dietary treatment, the mice were euthanized using CO2 asphyxiation and the stomach,
ileum, caecum, proximal and distal colon were excised from a random 2 mice per group for
the detection of species and changes in community structure. The contents of each individual
section were collected in I ml cryoprotective media (Crowther, 1971) and stored at -80 ”C.
Cryoprotective media was made up as follows; 5 g of Lab-Lemo (Oxoid) and 50 ml glycerol
was dissolved in 500 ml of distilled water. The pH was then adjusted to 7.3 and brought to
final volume of 500 ml with distilled water and then autoclaved at 110 °C for 20 min.
Bacterial strains and growth conditions
The stains Lactobacillus acidophilus DSM20079^, Lactobacillus agilis DSM20509’,
Lactobacillus amylovorus DSM20531 \ Lactobacillus braves DSM20054', Lactobacillus
crispatus DSM20584', Lactobacillus fermentum DSM20052', Lactobacillus johnsonii
DSM10533\ Lactobacillus mucosae DSM13345\ Lactobacillusplantarum DS1V120174^,
Lactobacillus reuteri DSM20016^, Lactobacillus salivarius DSM20555^, Lactobacillus
vaginalis DSM5837\ Lactobacillus intestinalis DSM6629^ Lactobacillus murinus
DSM20452^, were used as reference strains. Lactobacilli were routinely cultured at 30 °C or
37 °C on MRS medium (Difco). This was prepared by weighing out 52 g of MRS broth
(Oxoid) and dissolving completely in 1 L of distilled water at 60 °C and autoclaving at 121
°C for 15 min.
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Microbial cell counts of bifidobacteria, lactobacilli and coliforms
Faeces taken on days 0, 4,8,11 and 14 were subjected to microbial cell count analysis.
Briefly, viable cell counts of the predominant bacteria were determined by plating on media
selective for bacterial groups shown in parentheses: MacConkey agar no. 3 (Oxoid)
(coliforms; Bello et al, 2001), Rogosa SL agar (Fluka) (lactobacilli, after 48 h; Tannock et
ai, 2000), Rogosa SL agar (bifidobacteria, after 96 h; Tannock et al, 2000). The incubation
was performed anaerobically at 37 °C for 48 h, except for coliforms (aerobically, 1 day).
DNA extraction from pure cultures of Lactobacillus
Lactobacillus colonies were grown on MRS agar plates and harvested by adding at least 1.5
ml sterile deionised water to recover a 1 ml cell suspension. Bacterial cells were washed
twice using 1 ml of phosphate buffered saline (PBS, pH 8.3). DNA was extracted from 200 pi
of cell suspension. For cells lysis, 5 pi of lysozyme (Sigma) (10 mg/'ml in Tris-HCl, pH 8)
and 10 pi of mutanolysin (Sigma) (20 mg/ml in H2O) were added and incubated at 37 °C for 1
h. DNA was extracted and purified using the Roche ‘High Pure PCR template preparation
kit’ according to the manufacturers’ instructions. The eluted DNA was stored at -20 °C for
further analysis.
Extraction of DNA from faecal samples
Faecal samples stored at -80 °C were thawed on ice. Microbial DNA was extracted as
described by Walter et al, (2001).
PCR amplification of microbial DNA for DGGE analysis
PCR was performed using a 3000 thermocycler. The reaction mixture (50 pi) contained 25pmol of each primer, 0.2 mM of each deoxyribonucleotide triphosphate, 1/10 volume of lOx
reaction buffer, 20 mM concentration tetramethylammonium chloride, 25 pg of bovine serum
album, 2.5 U ofTaq DNA polymerase (Promega) and 2 pi of DNA. Lactobacillus groupspecific PCR was perfonned using LAC 1 and Lac 2-GC (Walters/ al, 2001) which
produced a 340 base-pair amplicon of the 16 rDNA gene. In this case, the amplification
program was 94 °C for 2 min; 34 cycles of 94 °C for 30 s, 61 °C for 1 min, and 68 °C for 1
min; and finally 68 °C for 7 min.
Lactobacillus identification ladder
For PCR-DGGE analysis, a Lactobacillus ladder was constructed using the DNA extracted
from the most common Lactobacillus species found in the murine GIT and from
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Lactobacillus found in a range of animals (Walter, 2005). The primer set described by Walter
(2001) was used, namely Lacl and Lac2.
Denaturing gradient gel electrophoresis (DGGE)
DGGE was performed as described previously (Walter et al, 2000) with the following
modifications: the gel contained a 32.5 to 50% gradient of urea and formamide increasing in
the direction of electrophoresis. Electrophoresis was performed at 130 V and 60

for about

5:30 h. Gels were stained with a 5 pg/ml ethidium bromide solution for 20 min, washed with
deionised water and viewed by UV trans-illumation (Montesi et al., 2005).

Results
Microbial cell counts in murine faecal samples after feeding EPS
Microbial cell counts were determined to determine the effect of the above EPS diets on three
distinct populations of bacteria, namely, lactobacilli, bifidobacteria and coliforms. Faecal
sample analysis of the basal (control) diet indicated that the coliforms were present at
approximately 10^ CFU/g (Figl. A). Fluctuations in coliform numbers were observed
throughout the 14-day feeding trial, with no distinct trend. Coliform counts in the inulin diet
showed a statistically significant reduction from day 0 to day 4 and from day 8 to day 11.
However, there was a statistically significant increase in coliforms from day 4 to day 8. In the
case of the EPSf28 diet, a statistically significant reduction in coliform counts was revealed
from day 0 to day 4 and from day 8 day 11. But there was also a statistically significant
increase in coliforms from day 4 to day 8. The data for the EPSmgi diet revealed a slight
overall increase in coliforms between day 0 and day 14, although fluctuations were evident
(Fig 1. A). An overall reduction in coliform counts was observed in mice fed inulin and
EPSf28 between days 0 and 11. In the case of Lactobacillus, analysis of the basal diet group
revealed a statistically significant reduction in counts throughout (Figl. B). Data observed for
the inulin diet showed that a statistically significant increase in Lactobacillus counts between
day 0 and day 8. The mice fed the EPSf28 diet showed a statistically significant reduction in
Lactobacillus counts between day 0 and day 14. The mice fed the EPSmgi showed a similar
trend, with a statistically significant decrease in Lactobacillus counts between day 0 and day
14. Data observed for bifidobacteria revealed the presence of bifidobacteria in the EPSf28 diet
towards the end of the trial on day 14. In the case of the EPSmgi diet, bifidobacteria appeared
sooner on day 4 followed by an increase in counts up to day 11. This was followed by a slight
reduction between days 11 and day 14. Interestingly, inulin did not induce the appearance of
78

bifidobacteria in this trial. In the control diet, bifidobaeteria did emerge on day 11 and was
still present on day 14.
Lactobacillus population shifts in faecal samples of mice after consumption of different
EPS diets
Two animals were randomly chosen from each of the four diet groups and their faecal
samples analysed for specifie Lactobacillus species. Four Lactobacillus species are
commonly associated in the GIT of mice, namely, L. johnsonii, L. murinus, L. intestinalis,
and L. reuteri (Walter, 2005). Of these, the latter three were detected in the majority animals
in this study. In the animals fed the basal diet, L. murinus and L. intestinalis were present.
The results in Table 2 indicated that the basal diet brought about no change in the
Lactobacillus species composition from day 0 to day 14. In the presence of 5% inulin, L.
murinus, L. intestinalis, and L. reuteri were present at day 0. On day 14, L. murinus was no
longer detectable, although the other two species were still present. In the case of the EPSf28
diet, L. murinus, L. intestinalis, and L. reuteri were also present at day 0 and significantly, the
three species were maintained on day 14. The profile was similar in the case of the EPSmgi
diet.
Sites of colonisation of the GIT by Lactobacillus species
The same two animals/group used in the previous section were then slaughtered and the
contents of their stomach, ileum, caecum, proximal and distal colon were also analysed by
DGGE in order to find the specific GIT location where colonization by the different
Lactobacillus species occurred (Table 3). It was found that the Lactobacillus species detected
in the stomach (Table 3. A), regardless of diet were L. reuteri and L. intestinalis. The species
L. murinus was present in the stomach of the animals on the basal diet and on the EPSf28 diet.
In the ileum (Table 3. B) L. reuteri was present in all diets, with the exception EPSf28- L.
intestinalis was detected in the ileum with all diets. L. murinus was present in the ileum
samples of the animals fed the basal diet and the EPSf28 diet. In the caecum, L. reuteri and L.
intestinalis were detected in the case of all diets (Table 3. C). L. murinus was only detected in
the mice fed the basal diet and the EPSf28 diet. In the proximal colon (Table 3. D) L. reuteri
was detected in the basal diet and the inulin diet but was absent in the two EPS diets. L.
murinus was detected in the basal diet and the EPSf28 diet. L. intestinalis was detected in the
proximal colon in the case of all diets. In the distal colon (Table 3. E) L. reuteri was present
in all diets, with the exception EPSmgi - L. murinus was detected in the basal diet and the
EPSf28 diet. L. intestinalis was detected in the proximal colon of mice fed all diets.
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Discussion
The gut microbiota of mice is not identical to that of humans but conforms to the general
features of bacterial communities in the large bowel of mammals; oblgately anaerobic
bacteria are the numerically predominate members of the microbiota (Salzman et al, 2002).
The aim of the present study was to investigate whether the two EPSs, namely EPSf28 and
EPSmgi had any influence on the populations of Lactobacillus, bifobacteria and coliforms.

These dietary supplements were administered with a basal diet and compared with inulin,
which was used as a control prebiotic. The basal diet (AIN-93G) provided the nutritional
requirements of 2-week-old mice (Reeves et al., 1993). Inulin is a fructo-oligomer isolated
from chicory root; it has been shown to stimulate the growth of bifidobacteria in several welldesigned in vitro studies using either pure bacterial cultures or undefined cultures of GI origin
(Apajalahti et al., 2002).
Microbial data in this study showed there were fluctuations in coliform numbers throughout,
with no distinct trends occurring. Both the inulin and the individual LAB-EPS diets showed
no major difference in lactobacilli numbers. This contrasts with the findings of Montesi
(2005) who fed rats a diet supplemented with a prebiotic additive containing fructooligosaccharides. The results from that study showed the prebiotic caused a reduction in
coliform counts and an increase in Bifidobacterium counts. However, similar to our findings,
there was no increase in lactobacilli counts. Data observed for bifidobacteria counts revealed
the presence of bifidobacteria after feeding an EPSmgi diet with their emergence occurring on
day 4 and with slight reductions between days 11 and days 14. Bello et al, (2001) analysed
batch cultures inoculated with human faeces to study the prebiotic properties of levan-type
EPS. The results from this study showed the EPS favored the growth of bifidobacteria. The
results from our study showed that our EPSmgi diet had similar effects, albeit with a slight
reduction towards the end of the trial. Gibson and Wang (1994) carried out an in vitro study
which showed a preferential stimulatory effect on numbers of the genus bifidobacteria, whilst
the populations of Escherichia coli and Clostridium were unaffected. Interestingly however,
in our study, inulin did not induce the appearance of bifidobacteria.
Although the LAB-EPS diets did not cause an increase in the growth of lactobacilli, a slight
shift in the population composition was evident though the use of denaturing gradient gel
electrophoresis. In the faecal samples, L. murinus, L. intestinalis and L. reuteri were the

Lactobacillus speices most commonly detected, regardless of the diet. L. reuteri could not be
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detected in animals fed the basal diet. As previously stated by Walter (2005) the most
commonly detected Lactobacillus species in the GIT of mice are L. johmonni, L. murinus, L.
intestinalis and L. reuteri and thus our findings broadly agree with this, with the exception of
L. johnsonni. Regardless of the diet, L. intestinalis was detected in the stomach, ileum,
caecum, proximal colon and distal colon, suggesting that this species is a stable member of
the microflora in these animals. In conclusion, both EPS diets showed no major changes in
coliform or lactobacilli populations, while the EPSmgi diet appeared to favour the growth of
bifidobacteria.
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Figure 1. (A) Effects of basal, basal + 5% inulin, basal + 5% EPSF28or basal +
5% EPSmgi on coliform counts from day 0-day 14 in murine GIT. (B) Effects of
basal, basal + 5% inulin, basal + 5% EPSF28or basal + 5% EPSmgi on
Lactobacillus counts from day 0-day 14 in murine GIT. (C) Effects of basal,
basal + 5% inulin, basal + 5% EPSp^sor basal + 5% EPSmgi on Bifidobacterium
counts from day 0-day 14 in murine GIT.
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Chapter 5
Discussion
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Throughout this thesis, two exopolysaccharides (EPS) from Weissella kimchii F28 and
Weissella confusa MGl were isolated and applied to murine diets. These EPSs,
designated EPSf28 and EPSmgi, were chosen on the basis of the fact that their respective
producer bacteria generated large amounts of each in comparison with other EPSproducing lactic acid bacteria. Both EPSs were characterised as glucans, which are
known to be formed from exogenous sucrose by the activity of a single enzyme
glucansucrase (De Vuyst & Degeest, 1999; van Hijum et al, 2006).
The objective of chapter 2 was to establish methodology for hyper-production of the two
exopolysaccharides from sucrose by their respective host bacteria. The protocol which
was initially chosen was modified slightly. Typical modifications to the protocol included
extending the incubation time, increasing the culture volume and extending the
lyophilisation time. In the case of EPSf28, the isolation procedure was followed six times,
making minimum modifications in order to optimize the yield of EPS. The maximum
yield of EPS for this strain was 16 g per litre of culture. In the case of EPSmgi? the
isolation procedure was followed five times, making minimum modifications in order to
optimize the yield of EPS. The maximum yield of EPS for this strain was 34.4 g per litre
of culture. By any standards, this is a very substantial yield of polysaccharide. By
carrying out these modifications optimum EPS yields were achieved.
The objective of chapter 3 was to determine the parameters necessary for a successful
murine feeding trial with the two EPSs by carrying out a number of preliminary mouse
feeding trials. Mice are utilised in feeding trials as the gut microbiota of mice, while is
not identical to that of humans, conforms to the general features of bacterial communities
in the large bowel of mammals. Obligate anaerobic bacteria have been reported as the
numerically predominant members of the microbiota (Salzman et al, 2002). In feeding
trial 1, the parameters were established to determine whether frozen samples versus fresh
samples were better for bacterial survival. It was concluded that the frozen samples were
acceptable, as minimal cell death occurred in the presence of cryoprotective medium. It
was established that, on dissection that the stomach of a mouse which had been fed the
basal diet was swollen and full of gas and liquid. On further examination of the spleen it
could be seen that no infection was present, indicating that the bloating was not due to a
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bacterial infection. The caecum appeared much smaller than normal and it was difficult to
distinguish between proximal and distal colon. Further investigation of this bloating of
the stomach was addressed in trial 3. Feeding trial 2 was designed to determine which
bedding conditions were best for the mice for the duration of the trial. The data obtained
suggested that the use of a wire base was more effective than bedding as it prevented the
mice, which are copraphyic, from eating their own faeces. Feeding trial 3 was designed to
determine methodology for calculating bacterial counts in caecum material, as well as
addressing the basis for the bloating of the stomach observed in some mice during this
trial. It was hypothesed that the basal diet AIN-93M was causing this problem, despite
the fact that it was previously used in murine feeding trials in the scientific literature.
Therefore it was decided to use an alternative diet, designated AIN-93G, which is more
suitable for growing mice and animals during pregnancy and lactation. The previously
used AIN-93M diet has a lower protein and fat content and generally recommended only
for adult maintenance (Reeves et al, 1993). Feeding trial 4 was designed to evaluate the
new basal diet (AIN-93G) and the effect that 5% inulin, 5% EPSf28 and 5% EPSmgi
supplements would have on the gut microflora. It was found that the AIN-93G diet was
superior to AIN-93M, causing no discomfort or bloating in animals. The 5% level of EPS
used in this trial was adhered to subsequently, as it did not cause any problems with
respect to reconstitution with the basal diet and acceptability to the animals. This trial
also supported the need for an anaerobic tent, due to the anaerobic nature of
bifidobacteria. The conclusions that were drawn from each of these preliminary trails
enabled the main feeding trial study to be designed. The parameters included twenty four
GDI mice (17-24 days old). The mice were randomly divided into four groups of six
mice and were housed one group per cage with a wire grid on base of cage and fed one of
the following four diets: basal diet alone (ArN-93G), basal diet plus 5% inulin (positive
group), basal diet plus 5% EPSf28 (F28 group) and basal diet plus 5% EPSmgi (MGl
group). The dietary treatments were to last for 14-days. When carrying out microbial cell
counts, the use of an anaerobic tent for both lactobacilli and bifidobacteria was necessary.
Therefore, this apparatus was used subsequently in the main feeding trial. Thus the
parameters for the main feeding trial were considered reliable.
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The aim of the Chapter 4 was to investigate whether the two EPSs, namely EPSf28 and
EPSmgi had any influence on the populations of Lactobacillus, bifobacteria and coliforms

in the murine gut. These dietary supplements were administered with a basal diet and
compared with inulin, which was used as a control prebiotic. The basal diet (ArN-93G)
provided the nutritional requirements of 2-week-old mice (Reeves et ai, 1993). Inulin is
a fructo-oligomer isolated from chicory root; it has been shown to stimulate the growth of
bifidobacteria in several well-designed in vitro studies using either pure bacterial cultures
or undefined cultures of GI origin (Apajalahti et ai, 2002). Microbial data in this study
showed that there were fluctuations in coliform numbers throughout with no distinct
trend occurring. Both the inulin and the individual LAB-EPS diets resulted in no major
difference in lactobacilli numbers. This contrasts with the findings of Montesi (2005),
who fed rats a diet supplemented with a prebiotic additive containing fructooligosaccharides. The results from that study showed that the prebiotic caused a reduction
in coliform counts and an increase in Bifidobacterium counts. However, similar to our
findings, there was no increase in lactobacilli counts. Data observed for bifidobacteria
counts revealed the presence of bifidobacteria after feeding an EPSmgi diet, with their
emergence occurring on day 4 and with slight reductions between days 11 and days 14.
Bello et ai, (2001) analysed batch cultures inoculated with human faeces to study the
prebiotic properties of levan-type EPS. The results from this study showed that EPS
favored the growth of bifidobacteria. The results from our study showed that our EPSmgi
diet had similar effects, albeit with a slight reduction towards the end of the trial. Gibson
and Wang (1994) carried out an in vitro study which showed a preferential stimulatory
effect on numbers of the genus bifidobacteria, whilst the populations of Escherichia coli
and Clostridium were unaffected. Interestingly however, in our study, inulin did not
induce the appearance of bifidobacteria. Although the LAB-EPS diets did not result in an
increase in the growth of lactobacilli, a slight shift in the population composition was
evident through the use of denaturing gradient gel electrophoresis. In the faecal samples
L. murinus, L. intestinalis and L. reuteri were the Lactobacillus speices most commonly
detected, regardless of the diet. L. reuteri could not be detected in animals fed the basal
diet. As previously stated by Walter (2005), the most commonly detected Lactobacillus
species in the GIT of mice are L. Johnsonni, L. murinus, L. intestinalis and L. reuteri, and
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thus our findings broadly agree with this, with the exception of L johnsonni. Regardless
of the diet, L.intestinalis was detected in the stomach, ileum, caecum, proximal colon and
distal colon, suggesting that this species is a stable member of the microflora in these
animals. In conclusion, both EPS diets showed no major changes in coliform or
lactobacilli populations, while the EPSmgi diet appeared to favour the growth of
bifidobacteria.
In conclusion, each of the first two technical stages in the project was successful in
overcoming the different challenges, namely setting up parameters to generate sufficient
EPS material and establishing murine feeding parameters. Significantly, Chapter 4 clearly
established that one of the novel EPSs, namely EPSmgi, certainly did have a prebiotic
effect in that it gave rise to higher levels of bifidobacteria in the intestine of mice.
Future experiments might include repeating the experiment with a significant increase in
the number of mice being utilized for the denaturing gradient gel electrophoresis stage.
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Appendix 1
16s ribosomal RNA typing data associated with the
two EPS producers in this thesis
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Introduction
This appendix is concerned with the 16s rRNA (ribosomal ribonucleic acid) typing of the two
EPS producing Weissella used in the thesis. A new standard for identifying bacteria was
developed in the 1980s (Clarridge et al, 2004). Woese et al, (1985) showed that
phylogenetic relationships could be determined by comparing a stable part of the genetic
code. The part of the DNA now that is most commonly used for taxonomic purposes is the
16s rRNA gene. This gene is approximately 1,550 bp long and is composed of both variable
and conserved regions (Clarridge et al, 2004). The methodology has been adapted for lactic
acid bacteria as described below.
DNA extraction from the two EPS producers
EPS producers were grown on MRS agar plates and harvested by adding at least 1.5 ml
sterile deionised water to recover a 1 ml cell suspension. Bacterial cells were washed twice
using 1 ml of phosphate buffered saline (PBS, pH 8.3). DNA was extracted from 200 pi of
cell suspension. For cells lysis, 5 pi of lysozyme (Sigma) (10 mg/ml in Tris-HCl, pH 8) and
10 pi of mutanolysin (Sigma) (20 mg/ml in H2O) were added and incubated at 37 °C for 1 h.
DNA was extracted and purified using the Roche ‘High Pure PCR template preparation kit’
according to the manufacturer’s instructions. The eluted DNA was stored at -20 °C for further
analysis.
PCR for 16s sequencing amplification
PCR was performed using a 3000 thermocycler. The reaction mixture (50pl) contained 25pmol of each primer, 0.2 mM of each deoxyribonucleotide triphosphate, 5x reaction buffer,
25mM Magnesium Chloride, 2.5 U of Taq polymerase (Promega) and 2 pi of DNA. 16s
sequencing amplification was performed using universal primers 16F and 16R (Weisburg et
al., 1991), which produced a 1500 base-pair amplicon. In this case, the amplification program
was 94 °C for 4 min; 29 cycles of 94 °C for 30 s, 61 °C for 30 s, and 72 °C for 1 m; and
finally 72 °C for 7 min. PCR products were purified using the Quiagen "QIAquick PCR
Purification kit" according to manufacturer's instructions. The purified DNA was then sent to
MWG for sequencing analysis.
Primer
16F
16S

Ta 3le 1. Universal primers used for 16s sequencing of Weissella
Sequence
Product Size
(bp)
1500 bp
5’- AGAGTTTGATCCTGGCTCAG-3’
5’-ACGGCTACCTTGTTACGACTT-3’

Use
16s sequencing
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Figure 1. BLAST alignments of MGl (named as Weissella confusa in this thesis)
Score

Expected

Identifier

Description

774

0

gi|19296083B|gb|Er’74Bf:.l|

Uncultured bacteriuz

clone ECH

aai39c0£ 1€3 ribosoaial

RKA gene/ partial sequence

774

0

gi1192980824lgblEU^74a47.11

Uncultured baeteriux

clone ECH

aai37dl0 IfS ribososal

R)<A gene/ partial sequence

774

0

gi|lf927f301|gblEU4£0B2f.11

Uncultured bacteriua

clone ECH

aaiSGgll 1£S iibosoaal

RKA gene, partial sequence

774

0

gi|lf927€271|gblEU4f079f.11

Uncultured bacteriua

clone ECB

aai36c04 1£3 ribososal

RSA gene, partial seguence

774

0

giIlf9274277|gb|EU458802.11

Uncultured bacteriuz

clone ECH bll 1£3 ribosomal RNA gene, partial sequence

774

0

giIlf9274273|gblEU45a79e.11

Uncultured bacteriux

clone ECH bOS 1€3 ribosonial RKA gene, partial sequence

774

0

gi1184202187IgblEUf00924.11

Veissclla sp. KIDS 7.07Q2 2.(3 ribosoaal RHA gene, partial sequence
Uncultured Veissella sp. partial 1C3 rRHA gene, clone 40ir04loral)

774

0

gi1 If284f451Icsb1^X420124.11

774

0

gil157785724IgbIEU157913.il

aeissella

sp. SfiiZSOB 1£3 ribososal RHA gene, partial sequence

774

0

gi|157907349|db;|AE3f2fl7.1|

Veissella

cibaria gene for IfS rRKA,

partial sequence,

strain: KRIC 013£

774

0

gi|15790734fIdb;IAB3f2fl4.11

Veissella

cibaria gene for IfS rRHA,

partial sequence,

strain: KRIC 0133

774

0

gr|157907340ldbjIAE3f2f08.1|

Veissella

cibaria gene for IfS rRKA,

partial sequence,

strain: )niIC 01Z7

774

0

gi1148710384IgblEff08531.11

Uncultured bacteriua clone PCC~S1 1£3 rib-ososal RKA gene, partial sequence

774

0

gi|125€29493|eablAM49ie20.1l

Veissella cibaria partial IfS rRKA gene, isolate R~3ZCS0

774

0

gi 1121485984 |gti|Eri07f 14.11

Veissella sp. RrtS lf3 ribososal RKA gene, partial sequence

774

0

gil10242127|gblAr252318.11

Uncultured bacteriua pPDS lf3 ribososal RKA gene, partial sequence

774

0

gillBf44190IgbIAF3714Bl.il

Uncultured bacterium

clone p~Z734~Z4ES If3 ribososal RKA gene, partial sequence

774

0

gi|lBf44ie9|gb|Ar3714B0.1|

Uncultured bacteriua

clone p-!770-Z4ES lf3 ribososal RKA gene, partial sequence

774

0

gi133590379IgbIAy281294.11

Veissella

biachii lf3 ribosoaal RKA gene, partial

sequence

774

0

gi|970e3862|gblDQ37£918.1|

Veissella

sp. ASb lf3 ribosoaal RKA gene, partial

sequence

774

0

gi|2121B3f'IgbIAF510730.il

Veissella

confusa lf3 ribosoaal RKA gene, partial sequence

774

0

gi12f801228leabIAJ422031.il

Veissella

cibaria lf3 rRKA gene, strain ACA~DC 3411tZ

774

0

gil84310209IgbIDQ321751.il

Veissella confusa strain Inje IM 3~33B lf3 ribososal RKA gene, partial sequence
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Query:

161
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Figure 2. BLAST alignments of F28 (named as Weissella kimchii in this thesis)
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Seissella confusastrain tlf-l 1£3 ribosoaal lUiA gene, partial sequence
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gi|157907349ldb;|ie2£2£17.1| Missella cibaria gene for 1£3 rRKA, partial sequence, strain; KRIC 013£
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Uncultured bacteriux clone ECE aai37dl0 1£3 ribosoaaal RKA gene, partial sequence
Uncultured bacteriua clone ECE aai3Sgll 1£3 ribosoaal RKA gene, partial sequence
Uncultured bacterius clone ECE bll 1£S ribcscaal RHA gene, partial sequence
Uncultured bacteriuB clone ECE bOS 1£S ribcscaal RHA gene, partial sequence

strain: KRIC 0133
strain; HRIC 0127

Uncultured bacteriux clone FCC'Sl 1£3 ribcscaal RHA gene, partial sequence

Uncultured bacteriux clone p'*2770'24£5 1£3 ribosoaal RKA gene, partial sequence
Seissella biaciui 1£3 ribosoaal RHA gene, partial sequence
Seissella confusa 1£3 ribosoaal RHA gene, partial sequence
Seissella cibaria 1£3 rRHA gene, strain ACA'DC 3411t2
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0
0

gi|2£80122S|eab|U422031.1|
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Seissella sp. Hn7~112 1£3 ribosoaal RHA gene, partial sequence
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Seissella confusa strain In;e I3i 3~336 1£3 ribosoaal RHA gene, partial sequence
cibaria
cibaria
confusa
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strain Uga49'3 1£3 rRHA gene, ccaclete sequence
partial 1£3 rRHA gene, strain IMG 1?£99T
CHA for 1£3 ribosoal RHA, strain J3( 1093
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Subject:

887
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11111111111111111111111111111 n 111111111111111111 M 111111111
CAGGGTArCTAAXCCTGTTTSCTACCCACACrTTCCAeCCrCAACGTCSbfiTrACAGTCCA 746
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Findings. The type strain for Weissella cibaria is LMG 17699. The two isolates used in this
thesis, while they are generally known as Weissella by collaborators on this project {confusa
in the case of MGl and kimchii in the case of F28). The original species names have been
kept throughout this thesis to avoid confusion. As new information continues to be inputted
into the databases on Weissella, which is a relatively new Genus, the speciation may diversify
further.
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